



Multi-Modal Imaging Techniques for Early Cancer Diagnostics  
by 
Noah Bedard 
Cancer kills more Americans under the age of 75 than any other disease. 
Although most cancers occur in epithelial surfaces that can be directly visualized, the 
majority of cases are detected at an advanced stage. Optical imaging and spectroscopy 
may provide a solution to the need for non-invasive and effective early detection tools. 
These technologies are capable of examining tissue over a wide range of spatial scales, 
with widefield macroscopic imaging typically spanning several square-centimeters, and 
high resolution in vivo microscopy techniques enabling cellular and subcellular features 
to be visualized. This work presents novel technologies in two important areas of optical 
imaging: high resolution imaging and widefield imaging. For subcellular imaging 
applications, new high resolution endomicroscope techniques are presented with 
improved lateral resolution, larger field-of-view, increased contrast, decreased 
background signal, and reduced cost compared to existing devices. A new widefield 
optical technology called multi-modal spectral imaging is also developed. This technique 
provides real-time in vivo spectral data over a large field-of-view, which is useful for 
detecting biochemical alterations associated with neoplasia. The described devices are 
compared to existing technologies, tested using ex vivo tissue specimens, and evaluated 
for diagnostic potential in a multi-patient oral cancer clinical trial.  
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1.1.  Objectives and Specific Aims 
The objective of this research is to develop improved optical imaging techniques 
for cancer detection and to evaluate their diagnostic potential. A promising procedure for 
optical diagnostics is to use a two-step approach where widefield imaging is used to 
identify suspicious regions within a large area of tissue, and then high resolution 
endomicroscopy is used for the final diagnosis. This work presents advancements in both 
widefield imaging and high resolution endomicroscopy techniques. To improve upon 
current endomicroscope devices, new techniques are presented that (1) expand the field-
of-view, (2) increase lateral resolution, and (3) provide axial sectioning. To improve 
widefield imaging, a new spectral imaging modality is developed that allows 
visualization of spectral features over a large field-of-view. The techniques are tested on 
ex vivo and in vivo tissue specimens and also evaluated in an oral cancer clinical trial.  
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The specific aims are as follows:  
Specific Aim 1: Develop and test high resolution endomicroscope systems and 
techniques that improve existing clinical devices and support miniature endoscope 
objective lenses. 
Specific Aim 2: Develop a multi-modal widefield spectral imaging device and evaluate 
its diagnostic value for oral cancer in a pilot clinical study. 
The impact of this work is to provide new effective and user-friendly tools that increase 
clinicians’ ability to diagnose cancer at the point-of-care. Knowledge gained through this 
research will facilitate integration of improved imaging technologies for cancer screening 
and surveillance.  
1.2. Overview 
This dissertation describes the development of (1) high resolution 
endomicroscope techniques and (2) a widefield spectral imaging technology for cancer 
diagnosis. It presents four endomicroscope technologies, a multi-modal widefield 
imaging spectrometer, and an oral cancer clinical study. The organization of the 
dissertation is as follows. 
Chapter 1 lists the specific aims of the research and provides a brief overview of 
the topics to be discussed. 
Chapter 2 provides background information on oral cancer statistics and disease 
progression.  
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Chapter 3 discusses the role of optical imaging for detection and diagnosis of 
cancer. The content is, in extenso, the work published in [1]. It provides an overview of 
multi-modal optical imaging, with an emphasis on low-resource settings. Concepts in 
widefield autofluorescence imaging, high resolution endomicroscopy, and combined two-
step optical screening are discussed and implemented in a proof-of-concept system. 
Chapter 4 presents a technique to increase the field-of-view of endomicroscopes. 
Details of the algorithm are given and the method is tested on tissue specimens. 
Chapter 5 presents two techniques to provide axial sectioning in 
endomicroscopes. The design and construction of each device is described. The devices 
are compared with existing high resolution imaging technologies and tested on tissue 
specimens.    
Chapter 6 presents a technique to increase lateral resolution of an endomicroscope 
using spectral encoding. The implementation and calibration of the new modality is 
described. The device is tested on standard optical targets and an in vivo tissue specimen.  
Chapter 7 introduces a new spectral imaging device. Calibration and 
characterization of the device is described. Oxygen saturation maps of tissue are also 
shown. 
Chapter 8 presents the design and construction of a multi-modal widefield 
imaging spectrometer for clinical studies. Optical specifications, software, and the design 
of a clinical trial are described. Autofluorescence/reflectance images and spectra are 
shown for different tissue regions.  
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Chapter 9 summarizes the results of the various technologies, reviews the impact 






2.1. Motivation and Significance 
Cancer is the second leading cause of death in the United States. While over 80% 
of cancers occur in epithelial surfaces, most of which can be directly visualized, the 
majority of cases are detected at an advanced stage. The stage that the disease is detected 
is directly related to survival, therefore early detection is vital. The ultimate goal of this 
work is to develop optical imaging techniques for the early diagnosis of cancer in a 
variety of tissue sites. However, for the research reported here, we particularly focus on 
oral cancer, because the oral cavity is convenient model for device testing.  
Oral cancer is a major global health problem. Each year there are approximately 
310,000 new cases worldwide [2]. In the US alone, it is a significant problem with 34,000 
new cases and 7,550 deaths in 2007, yet the problem is much greater in developing 
countries [3, 4]. In India, for example, oral cancer is the most common cancer in men and 
the third most common cancer in women [4]. Localized disease can be more successfully 
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and easily treated than advanced disease, leading to an optimistic five-year survival rate 
[5]. Unfortunately, 2/3 of patients in the US are diagnosed with more advanced disease 
that leads to much greater mortality. The treatment for late stage disease is also more 
aggressive and can lead to permanent physical and physiological damage, which 
decreases quality of life.  
Although the need for early diagnosis is clear, there are many factors which 
contribute to delay. Localized oral cancer may appear benign to a physician and could 
remain unsuspicious until an advanced stage. Lesions that are suspicious should be 
biopsied to determine disease status, but the invasiveness of the procedure could lead to 
hesitation that prolongs diagnosis. Biopsies also takes time to process and examine, 
adding to patient stress and prolonging the time to diagnosis. 
2.2. Oral cancer disease progression 
The oral cavity includes the buccal mucosa, the upper and lower alveolus and 
gingiva, the hard palate, the tongue, and the floor of the mouth. Over 90% of oral cancers 
are squamous cell carcinomas, and most of these result from genetic alterations caused by 
years of tobacco and alcohol exposure [5, 6]. Stratified squamous cells line the oral 
mucosa and reside above the basement membrane and stroma. In normal tissue, tall basal 
cells line the basement membrane with progressively flatter cells approaching the surface, 
whereas in squamous cell carcinoma this differentiation does not occur. Dentists 
sometimes screen for white or red oral lesions, known as leukoplakia or erythroplakia 
respectively, which can indicate or accompany squamous cell carcinoma [7]. 
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Screening techniques for cancer are better understood by examining the 
pathophysiology of the disease. Cancer is generally defined as uncontrolled growth and 
spread of abnormal cells [8]. The development of an invasive cancer from normal cells 
follows a multi-step progression of genetic changes that usually takes years to occur.  The 
major defect in cancer cells is within the regulatory mechanisms that govern cell 
proliferation and homeostasis. From this fact, it has been suggested that all cancers have 
the same set of at least six functional capabilities, sometimes called the “hallmarks of 
cancer”: self-sufficiency in growth signals, insensitivity to anti-growth signals, tissue 
invasion and metastasis, limitless replicative potential, sustained angiogenesis, and 
evasion of apoptosis [9].  
These acquired capabilities of cancer are also associated with early morphological 
and biochemical changes at the cellular and tissue levels, which can allow precancer to be 
distinguished from normal tissue. Cancerous lesions are typically made up of genetically 
unstable, poorly differentiated, rapidly dividing cells. From early on, these cells cause a 
number of changes in the tissue that indicate precancer and such lesions are referred to as 
dysplasia. Recognized biochemical changes include changes in NADH and FAD activity, 
decreased collagen crosslinks, and an upregulation of proteins such as EGFR, HER2, and 
MMP [10-14]. The morphological alterations associated with these cells include: 
enlarged nuclei, hyperchromatic nuclei, pleomorphism, keratinization, loss of polarity of 
basal cells, and irregular epithelial stratification [7]. The best indicators for dysplasia are 
usually nuclear-to-cytoplasmic ratio (N/C), pleomorphic cells and nuclei, and increased 
nuclear chromatin. Histology with hematoxylin and eosin staining is used to analyze 
these characteristics, and is currently the gold standard for oral cancer diagnosis [15]. 
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Mild, moderate, and severe dysplasia are characterized by abnormal changes in the lower 
one-third, two-thirds, and entire epithelium, respectively. Dysplasia throughout the entire 
epithelium that has not invaded through the basement membrane is called carcinoma in 
situ [16]. Cancer that has progressed beyond the basement membrane is further classified 
into stages that relate to size, lymph node involvement, and spread to other regions of the 
body [6]. 
2.3. Optical imaging and spectroscopy for cancer diagnostics  
Current oral cancer screening techniques are generally inadequate, as evidenced 
by the fact that the 5-year survival rate for oral cancer has remained relatively unchanged 
for the last 30 years. Therefore, new technologies are needed to detect precancerous 
lesions. The optical detection technologies presented in this dissertation can be divided 
into two categories: widefield devices and high resolution devices (see Figure 2-1: Widefield and high resolution optical techniques for cancer detection.. Wide-field 
devices survey multiple centimeters of tissue at one time using specialized light sources 
and filters. These systems show increased visibility of tissue microvasculature and can 
reveal changes associated with tissue autofluorescence. Typically they can detect 
precancerous lesions with high sensitivity but can have false positives (such as 
inflammation, lichen planus, hyperkeratosis) which leads to low specificity. Ideally, a 
second high-resolution device is used to interrogate localized tissue properties. High-
resolution imaging is often called endomicroscopy or microendoscopy and includes 
devices such as confocal microscopy and OCT. These devices can reveal cellular 
morphology and function, which yields both high sensitivity and specificity. Another 
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technique called point spectroscopy can measure the reflectance and autofluorescence 
properties at a localized region of tissue, which is associated with changes in hemoglobin 
absorption as well as epithelial/stromal fluorescence. Preferably, high resolution devices 
will be used with wide-field techniques to enable screening that is both fast and effective. 
The following chapter expands on the role of multimodal optical imaging for early cancer 
detection.  
 




Emerging roles for multimodal optical 
imaging in early cancer detection* 
*The contents of this chapter have been published in the following journal article: N. Bedard, M. Pierce, A. El-Nagger, 
S. Anandasabapathy, A. Gillenwater, and R. Richards-Kortum, "Emerging roles for multimodal optical imaging in 
early cancer detection: a global challenge.," Technol Cancer Res Treat 9, 211-217 (2010). 
 
Medical imaging technologies have become increasingly important in the clinical 
management of cancer, and now play key roles in cancer screening, diagnosis, staging, 
and monitoring response to treatment.  Standard imaging modalities such as MRI, PET, 
and CT require significant financial resources and infrastructure, which limits access to 
these modalities to those patients in high-resource settings.  In contrast, optical imaging 
strategies, with the potential for reduced cost and enhanced portability, are emerging as 
additional tools to facilitate the early detection and diagnosis of cancer.  This chapter 
presents a vision for an expanding role for optical imaging in global cancer management, 
including screening, early detection at the point-of-care, biopsy guidance, and real-time 
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histology. Multi-modal optical imaging – the combination of widefield and high 
resolution imaging - has the potential to aid in the detection and management of 
precancer and early cancer for traditionally underserved populations.  Several recent 
widefield and high-resolution optical imaging technologies are described, along with 
requirements for implementing such devices into lower-resource settings. 
3.1. Medical Imaging and Cancer 
Medical imaging plays a central role in the detection and diagnosis of cancer.  
Screening, diagnosis, and staging all rely on the ability of imaging technologies to 
identify molecular and morphologic alterations associated with the onset and progression 
of neoplastic disease.  Current treatment paradigms also rely heavily on imaging, for 
image-guided therapy, minimally-invasive surgery, and to monitor treatment response.  
Computed tomography (CT), ultrasound, and magnetic resonance imaging (MRI) are 
well-established imaging modalities that can provide in situ anatomical data on the size, 
shape, and location of tumors.  Relatively newer technologies such as positron emission 
tomography (PET) and single-photon-emission CT (SPECT) add the ability to detect and 
monitor functional activity of tumors, revealing both the location and metabolic activity 
of disease.  Each of these imaging platforms can also take advantage of the growing array 
of molecularly-targeted contrast agents to detect and monitor distinct biochemical 
processes involved in neoplastic transformation [17, 18].  
While the enhanced capabilities of these imaging systems will continue to play a 
key role in improving patient care, the financial cost and infrastructure required to 
establish and maintain them restricts their use largely to regional healthcare centers in 
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industrialized countries.  This is clearly underscored by the disparity in the availability of 
these technologies.  As an example, a 2006 estimate placed the number of MRI machines 
in the US at around 11,000.  Two years later in 2008, the first MRI machine was installed 
in Malawi, and the system is currently shared with neighboring Mozambique and 
Zambia, two countries without a single MRI scanner.  Even in developing countries with 
rapidly emerging economies such as India, there are only 0.5 MRI machines per million 
inhabitants, compared to 37 machines per million persons in the US [19].  
Today, more than 70% of the world’s cancer deaths occur in these low- to middle-
income countries, where 80% of patients present with advanced disease at the time of 
diagnosis [20, 21].  These figures are unlikely to be affected by a widespread infusion of 
high-level imaging technology in the foreseeable future.  Even in developed countries, 
the presence of diagnostic imaging technology alone does not equate to widespread 
access.  Patients in the US who are uninsured or who have Medicaid insurance are 
significantly more likely to be diagnosed with late stage cancer, and have significantly 
lower survival rates than patients with private insurance [22].  At a time when the global 
incidence of cancer is rapidly increasing and 47 million Americans lack health insurance 
[23], there is an urgent need for effective and affordable tools and technologies to 
facilitate early detection, prevention, and treatment of cancer in low resource settings. 
Optical imaging is a new technology which may provide a potential solution to 
the global need for affordable imaging tools to aid in the early detection and management 
of cancer.  While healthcare providers have traditionally used optical tools such as 
endoscopes, colposcopes, and surgical microscopes in cancer management, a new 
generation of instruments is being developed which can detect not just reflected white 
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light, but additional signals arising from cancer biomarkers, carried in the fluorescence, 
polarization, and narrowband reflectance of light.  These systems are capable of 
examining tissue over a wide range of spatial scales, with widefield macroscopic imaging 
typically spanning several square-centimeters, and high-resolution in vivo microscopy 
techniques enabling cellular and subcellular features to be visualized [17, 24, 25].  
Optical instrumentation is relatively inexpensive, using mass-fabricated components 
developed by the telecommunications and consumer electronics industries.  A second key 
factor, which we focus on here, is the recent emergence of multimodal optical imaging 
systems, simultaneously providing wide-field and high-resolution optical imaging, within 
cost-effective, portable, and even battery-powered formats.   
This chapter presents our vision of an expanding role for optical imaging in 
cancer management, through the example of a dual-resolution portable device that has 
potential to aid in early cancer detection and management for socioeconomically diverse 
populations.   
3.2. Current Optical Imaging Techniques for Cancer 
Management 
Widefield Optical Imaging: An Emerging Technology for Cancer Screening  
Over 80% of malignancies occur in epithelial surfaces, most of which can be 
directly visualized [26].  Thus, many current procedures for cancer screening begin with 
visual inspection of the entire tissue surface at risk under white light illumination, often 
with additional low-power magnification.  These techniques can be improved with 
narrow-band reflectance imaging (NBI) and autofluorescence imaging (AFI) to enhance 
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visualization of the microvasculature and monitor alterations in epithelial and stromal 
fluorescence associated with the early development of neoplasia [27].  Figure 3-1 
illustrates the application of this technology to improve screening for lung cancer; white 




Figure 3-1: These images illustrate the application of light induced fluorescence endoscopy to 
improve screening for lung cancer with a widefield optical imaging system; white light and 
autofluorescence images acquired with light-induced fluorescence endoscopy (top, Xillix LIFE; 
bottom, Pentax 3000) show typical image features associated with atypical cells, with suspicious 
areas indicated by white arrows.  The white light images (A, C) represent the clinician’s 
conventional viewing mode, allowing anatomical inspection at low magnification.  
Autofluorescence images (B, D) are sensitive to the natural fluorescence of tissue, which 
originates predominantly from stromal collagen. The development of neoplasia is associated with 
loss of stromal autofluorescence and this loss of fluorescence intensity can be used to assist 
clinicians in identifying pre-cancerous and suspicious cancerous lesions (as shown by decreased 
fluorescence intensity within areas in B, D).   
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(Xillix LIFE, Pentax 3000) show representative image features associated with atypical 
cells.  The white light images (Figure 3-1a,c) represent the clinician’s conventional 
viewing mode, allowing anatomical inspection at low magnification.  Autofluorescence 
images (Figure 3-1b,d) are sensitive to the natural fluorescence of tissue, which originates 
predominantly from stromal collagen.  When illuminated with blue light, non-neoplastic 
tissue emits green fluorescent light.   
The development of neoplasia is associated with loss of stromal autofluorescence 
and this loss of fluorescence intensity can be used to assist clinicians in identifying pre-
cancerous and suspicious cancerous lesions (as evident in Figure 3-1b,d).  This technique 
has been used in over 1600 patients world-wide; studies support an improved sensitivity 
of autofluorescence bronchoscopy over white light bronchoscopy alone (80% versus 
40%) [28, 29].    
Imaging systems based on similar principles have been developed and tested for 
cancer detection in several other organ sites, including the esophagus, cervix, and oral 
cavity.  In 2008, Curvers et al. reported the results of a multicenter study that used white-
light endoscopy with the addition of NBI and AFI to detect neoplastic lesions in 84 
patients with Barrett’s esophagus, a precursor of esophageal cancer [27].  Use of AFI 
identified 11 patients with early neoplasia in addition to the 16 identified by white-light 
alone, raising the targeted detection rate from 53% to 90%.  These and other encouraging 
data from pre-clinical studies have led to the development of several commercially-
available widefield multi-spectral imaging systems with FDA approval for early cancer 
detection, including the VELscope (oral), the Trimira-3000 (oral), the Olympus Lucera 
(GI), and the Xillix LIFE scope (lung).  Newer spectral imaging techniques are being 
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developed to measure other cancer-related biomarkers such as total hemoglobin content 
and hemoglobin oxygen saturation, as a tool to detect tumor margins in vivo during 
surgery [30]. 
 
High-Resolution Optical Imaging: Applications in Early Detection, Margin Detection, 
and Real-time Histology 
 In current practice, tissue sites appearing suspicious for disease on visual 
inspection with white light are typically biopsied, enabling a pathologist to evaluate 
cellular morphology at the microscopic level.  Recently, high-resolution optical 
techniques have been developed that can image tissue with sub-cellular resolution in situ, 
revealing morphologic indicators of neoplasia such as increased pleomorphism, changes 
in nuclear size and nuclear density and the presence of abnormal mitotic features, in 
addition to functional indicators when used in combination with targeted optical contrast 
agents [25].  A high-resolution confocal endoscope for imaging the mucosal lining of the 
esophagus and colon was evaluated during in vivo clinical studies by Polglase et al., 
demonstrating the system’s ability to visualize microscopic features including goblet cells 
and columnar epithelial cells, traditionally used by the pathologist in the diagnosis and 
staging of disease [31].  In Figure 3-2, a confocal microendoscope was used to image 
excised ovarian tissue after the application of acridine orange [32].  Fluorescence 
imaging enabled visualization of individual nuclei and the underlying stroma (Figure 
3-2a-c).  Images from a healthy ovary were characterized by a homogeneous distribution 
of nuclei, whereas images from carcinoma revealed a disordered tissue structure and 
variable nuclear size (Figure 3-2a,d). Other more subtle pathologic changes such as 
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sclerosis and endometriosis were also detectable (Figure 3-2e,f).  These optical methods 
have been adapted for in vivo use at several organ sites, with a focus on guiding biopsy 
site selection to those locations with the highest diagnostic potential.  As with the wide-
field imaging systems described earlier, several high-resolution optical imaging systems 
have been commercialized and received FDA approval for cancer detection, including the 
Lucid confocal microscope, the Mauna Kea fiber-optic system, and the Pentax / Optiscan 
confocal endoscope. 
Figure 3-2: High-resolution confocal microendoscope images of excised ovarian tissue 
after the application of acridine orange.  Fluorescence imaging enabled visualization of 
individual nuclei and the underlying stroma (A-C).  Images from a healthy ovary were 
characterized by a homogeneous distribution of nuclei, whereas images from carcinoma 
revealed a disordered tissue structure and variable nuclear size (A, D). Other more subtle 
pathologic changes such as sclerosis and endometriosis were also detectable (E, F). 
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The same high resolution imaging techniques can potentially address the wider 
need for histopathology in settings where a pathology laboratory is either not available, 
less developed, or lacking expertise.  Gareau et al. demonstrated that high-resolution 
optical imaging in the form of confocal microscopy can be used for margin evaluation 
during Mohs surgery for patients with basal cell carcinomas, providing an accurate 
diagnostic result in a much reduced time of frozen section histopathology [33].  
 
Multimodal Optical Imaging 
Each of these widefield and high-resolution systems has recognized strengths and 
weaknesses.  In the same way that radiological imaging modalities have been combined 
to provide complementary diagnostic information (such as PET-CT, PET-MRI), 
widefield and high‐resolution optical imaging systems have begun to be integrated into 
single platforms.  In a 148‐patient clinical study, Lam et al. performed high-resolution 
optical coherence tomography (OCT) imaging at sites initially inspected by widefield 
autofluorescence bronchoscopy [34].  Following guidance to suspicious sites by 
widefield imaging, OCT was then used to measure the local epithelial thickness and 
identify enlarged nuclei, allowing invasive cancer to be distinguished from carcinoma in 
situ, and dysplasia to be distinguished from metaplasia, hyperplasia, and normal tissue.  
The autofluorescence endoscope described by Curvers et al. incorporated the additional 
use of narrowband reflectance imaging to improve diagnostic specificity in Barrett’s 
esophagus, as supported by a drop in the false positive rate from 81% to 26% [27].  It is 
likely that comprehensive screening and diagnosis of cancer will require the development 
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of such multi‐modal imaging platforms, with the ability to initially survey large tissue 
areas at risk to identify abnormal regions with high diagnostic sensitivity.  Targeted 
follow-up of those suspicious sites with high-resolution imaging can then be used to 
eliminate confounding factors such as inflammation that lead to false positive results, 
improving the overall specificity of cancer detection.  
 
Portable Optical Systems: Translating Optical Imaging to Low-Resource Settings 
While these optical imaging systems continue to demonstrate encouraging 
performance in clinical studies, they remain primarily a subject of research and validation 
in large referral hospital settings in industrialized countries.  However, by leveraging 
advances in optoelectronic components, low-power processing hardware, and digital 
image analysis, these imaging systems have the potential to be successfully adapted and 
integrated into low-resource settings, addressing the current gap in cancer screening and 
surveillance strategies in this environment.  A few examples of compact, battery-powered 
optical systems have been demonstrated, including portable colposcopes for cervical 
cancer screening [35, 36], and a hand-held visual inspection device for the oral cavity 
[37], each of which require the user to observe the tissue by eye.  
We recently developed a battery-powered, portable system, capable of both 
widefield and high-resolution digital imaging, and have begun clinical studies to compare 
its performance against large-scale counterparts.  The widefield imaging component was 
previously described by Rahman et al., consisting of a commercially available surgical 
headlight system modified to include LED illumination for both white light and 
fluorescence excitation, and a high‐sensitivity CCD camera for digital image acquisition 
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(Figure 3-3a)  [38].  This portable screening system weighs only 3 lb and can 
alternatively be mounted on a camera tripod.  The high-resolution imaging capability is 
provided by epi-illumination of a flexible 1 mm diameter fiber‐optic bundle, with the 
distal end of the fiber placed in contact with the tissue site to be imaged, following 
topical application of a fluorescent contrast agent.  Fluorescent light emitted from the 
tissue returns through the same fiber and is imaged onto a high-sensitivity CCD camera 
[39].  This system was engineered into a lightweight (6 lb) and portable package (Figure 
3-3b).  Both the widefield imager and the high-resolution microendoscope systems 
connect to a single laptop computer via IEEE-1394 (Firewire) ports, enabling 
Figure 3-3: Combined portable widefield and high-resolution imaging systems. (A) The 
portable screening system weighs only 3 lb. (B) High-resolution microendoscope 
contained in a briefcase. (C) Widefield and high‐resolution images of normal human oral 
mucosa acquired with the multimodal imaging system.  In the widefield image (left 
frame), the green autofluorescence of normal tissue is apparent, as well as the 
microvascular network.  The high‐resolution fiber-optic probe can be seen in contact 
with the mucosal surface, approaching from the base of the widefield frame.  The high-
resolution image, acquired simultaneously, is displayed in the lower right frame, with the 
800 m diameter field-of-view corresponding to the tissue located beneath the tip of the 
fiber-optic probe.  Following topical application of 0.05% proflavine solution to the 
probe tip, nuclei appear as discrete bright regions within each epithelial cell. 
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simultaneous imaging within a LabVIEW-based user interface (Figure 3-3c).  The total 
cost of components for the combined imaging platform was under $10,000. 
Figure 3-3c presents widefield and high‐resolution images of normal human oral 
mucosa acquired with the multimodal imaging system.  In the widefield image (left 
frame), the autofluorescence of normal tissue is apparent, as well as the microvascular 
network.  The high‐resolution fiber-optic probe can be seen in contact with the mucosal 
surface, approaching from the base of the widefield frame.  The high-resolution image, 
acquired simultaneously, is displayed in the lower right frame, with the 800 m diameter 
field-of-view corresponding to the tissue located beneath the tip of the fiber-optic probe.  
Following topical application of 0.05% proflavine solution to the probe tip, nuclei appear 
as discrete bright regions within each epithelial cell.  The diagnostic performance of this 
integrated imaging system is currently being evaluated in pre-clinical studies, in 
comparison with research-grade optical imaging systems, and against the gold-standard 
of histopathology.  
3.3. The Future of Optical Imaging for Global Cancer 
Management 
Emerging clinical data suggest that optical imaging may play a key role in cancer 
management from two perspectives.  First, optical methods can be used in vivo to acquire 
anatomical and functional images of tissue over a wide range of spatial scales, rapidly 
surveying large mucosal surfaces at risk to identify suspicious areas, and then 
interrogating those regions with sub-cellular spatial resolution.  This capability offers 
practical flexibility in diagnostic use, enabling optical methods to be used in areas 
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ranging from early-stage screening, to supplementing histopathology.  Second, 
technological advances made by the optoelectronics industry have produced high-
performance components which can be used to build portable, cost-effective imaging 
devices.  These features are necessary to support the sustainable dissemination of 
diagnostic imaging tools in remote areas and for traditionally underserved populations.  
We contend that these advantages of optical imaging technologies can be used to 
impact cancer management in several practical ways. The availability of optical imaging 
devices has the potential to streamline medical procedures, provide guidance to biopsy 
sites, and expedite margin determination to help reduce procedure costs, and improve 
surgical outcomes.  Cost-effective, portable devices such as the optical systems described 
here can potentially help fill crucial technological gaps in settings where the 
infrastructure to support traditional radiological imaging and pathology services available 
in industrialized countries, are neither available, nor affordable.  
 
Potential Roles and Requirements for Optical Imaging 
Expanding Access to Screening and Early Detection  
Screening high risk populations and early detection of cancer are critical to 
prevention, effective treatment and decreased morbidity of several types of malignancies. 
In low- and medium-resource countries, cancers of the stomach, liver, oral cavity, and 
cervix are common. Changes in diet and smoking habits are leading to increases in 
cancers of the lung, breast, esophagus, prostate, and colon [40].  Optical imaging is most 
applicable to cancers that develop in epithelial mucosal surfaces, due to the limited 
penetration depth of light. Optical screening methods have been applied to and are 
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currently the subject of significant research efforts for cancers of the oral cavity, cervix, 
lung, ovary, breast, esophagus, urinary bladder, skin, and colon (11, 12, 14, 15, 16, 21, 
28), and these technologies can potentially be translated to low-resource settings. 
Without improved screening programs in these settings, it is likely that most of 
these cancer patients will continue to be diagnosed at late stages when limited treatment 
options exist.  For instance, in Africa there is an overwhelming shortage of expertise for 
the operation and maintenance of medical equipment to deliver radiation therapy, and as 
a result, radiation treatment is only available to approximately 20% of the patients who 
need it [19].  Early diagnosis can reduce the burden on these limited resources by 
enabling simpler treatments to be provided for patients with early-stage disease.  In this 
respect, cervical cancer screening can serve as a positive model for prioritizing early 
detection of other cancers in developing countries.  It has been shown that screening 
women just once for cervical cancer and its precursors at age 35 can reduce the lifetime 
risk of developing cervical cancer by 25-36% [41].  When effective and economically 
viable treatment (cryosurgery in the case of cervical pre-cancer) can be administered, 
access to even minimal screening can clearly have a considerable benefit to an at-risk 
population.  
Clinical studies using widefield optical imaging have shown that inexpensive 
optical systems can be used for early detection of cancer in the oral cavity, with the 
VELscope specifically targeting the dentist’s office as a site for routine screening [37].  
In low-resource settings where healthcare providers are unlikely to have specific 
expertise in cancer detection, it is particularly important to provide practitioners with 
objective tools to guide diagnosis.  Most imaging devices require subjective evaluation, 
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but current research on image processing techniques enable optical devices with digital 
image capture to allow for objective assessment for pathologic abnormalities. For 
example, Roblyer et al. recently demonstrated a simple technique to detect and delineate 
oral neoplasia based on quantitative analysis of autofluorescence images [42].  In this 
study, autofluorescence images at 405 nm excitation were acquired with a color CCD 
camera.  Using linear discriminant analysis, a classifier was developed to distinguish 
neoplastic and normal regions of interest based on the ratio of red-to-green pixel 
intensities, resulting in 100% sensitivity and 91.4% specificity in a validation set.   
Objective analysis techniques can provide a repeatable way to determine the threshold for 
demarcating suspicious lesions, while also lessening the need for extensive user training. 
In primary care settings, optical imaging devices could offer health care providers 
effective screening tools, which can assist in identification of cancer at the earliest stages.  
Indeed, maintaining and expanding access to early screening is becoming increasingly 
important given the growing shift of poor and underinsured people towards suburban and 
rural areas, away from major metropolitan areas where most healthcare services are 
concentrated [43].   
Guiding Treatment through Real-Time Biopsy and Histology 
Optical imaging technologies can also be used to help clinicians in low-resource 
areas to diagnose and treat early malignancies. When a suspicious lesion is identified, the 
current practice in most developed countries is to perform an invasive biopsy to obtain 
tissue for histopathologic analysis. The ability to perform a biopsy is crucial for accurate 
diagnosis, but requires considerable physical infrastructure, personnel, and economic 
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resources.  High-resolution optical imaging can provide an alternative means of 
evaluating cellular morphology when histo- and cytopathology facilities are unavailable.  
Even in well-equipped centers, the ability of optical imaging to guide the clinician to 
sample the most appropriate sites may significantly reduce cost and improve the 
diagnostic value of biopsies obtained from the patient [44].   
Although results from current optical imaging technologies are promising, there 
are still several hurdles to overcome before these devices can be translated into low-
resource clinical settings.  First, better needs assessment studies are required to more 
effectively delineate design requirements and guide the development of appropriate 
technology for use in developing countries.  Such considerations include developing 
robust battery-powered devices for sites where electric power may be unreliable, 
designing devices which require minimal user expertise for settings where the availability 
of highly trained practitioners may be limited, and developing low-cost image contrast 
agents which can be stored safely for long periods in environments with potentially 
extreme temperatures and humidity levels.  Quality control of devices is also important in 
the developing world, to ensure that instruments can remain calibrated and functional 
over time in settings without trained technicians.  And finally, researchers and technology 
developers must overcome the relative lack of funding sources that enable non-profit and 
for-profit institutions to develop devices for low-resource settings and to carry out 
necessary field studies and translation of technology in the absence of traditional market 
incentives.  
Cancer is projected to become the world’s leading cause of death by 2030, with 
the burden of disease shifting further towards medically underserved populations in 
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industrialized countries and the developing world [26].  New approaches are required 
across the spectrum of cancer management, in prevention, diagnosis, treatment, education 
and care.  If developed and tested appropriately, optical imaging technologies can play an 
important role in several aspects, from providing objective diagnostic screening at the 
community healthcare level, to enabling pathology guidance in the clinical setting.    
Importantly, by delivering these technical capabilities within cost-effective platforms, the 
impact on public health can be magnified through expanding patient access to previously 
unreachable healthcare systems.  
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Chapter 4 
Expanding the field-of-view of 
endomicroscopes: video mosaicing* 
*The contents of this chapter are being prepared for submission as the following manuscript: N. Bedard, T. Quang, R. 
Richards-Kortum, and T. Tkaczyk, "Real-time in vivo video mosaicing with a high-resolution microendoscope," 
Biomed Opt Exp (2012). 
 
As discussed in Chapter 3, microendoscopy allows clinicians to view in vivo 
subcellular features in real-time and can be used for applications such as biopsy 
screening, point-of-care diagnostics, and disease progression studies. Although 
microendoscopes have excellent image quality, their field-of-view is inherently limited 
by the small size of the distal end, which can make it difficult for the user to navigate the 
tissue and obtain an accurate diagnosis. Video mosaicing has emerged as an effective 
technique to increase the acquired image size, but most implementations are performed 
post-procedure, thus diminishing the benefit of real-time tissue examination. In this 
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chapter we present an algorithm for real-time video mosaicing using a portable low-cost 
high-resolution microendoscope. We present execution times for each stage of the 
algorithm and show results from ex vivo and in vivo tissue samples. Video mosaics are 
also compared to images from a benchtop confocal microscope as well as histopathology. 
4.1. Introduction  
Histopathological examination of excised tissue is the standard of care for the 
diagnosis of epithelial cancers. During this procedure pathologists examine cellular 
features such as nuclear size, nuclear-to-cytoplasmic ratio, and architectural alterations. 
Microendoscopy is a type of optical imaging that allows clinicians to view these features 
in vivo at subcellular resolution, effectively bringing the microscope to the patient.  These 
non-invasive devices can (1) be used to screen biopsy sites in order to reduce the number 
of biopsies taken, (2) function as point-of-care diagnostic tools during surgical 
procedures, or (3) to monitor disease progression throughout longitudinal in vivo studies 
[45]. Although microendoscopes can have excellent resolution and light efficiency, their 
field-of-view (FOV) is inherently limited by the size of the probe’s distal end. In most 
microendoscopes the FOV is < 1 mm2, which is comparable to the field of a 40X 
microscope objective. This “tunnel vision” can make it difficult for users to obtain a 
broad sense of tissue morphology [46] and result in sampling error when imaging a 
heterogeneous tumor [47] .  
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Video mosaicing has been demonstrated as an effective tool for increasing the 
FOV acquired by microendoscopy. This technique stitches together consecutive video 
frames acquired as the probe is scanned over the tissue, thus creating a 2 – 30 times larger 
high-resolution image. Several papers have discussed development and clinical 
application of off-line video mosaicing using commercial confocal microendoscopes [48-
50]. These methods combine the frames of a saved video using non-rigid deformation 
algorithms and template matching. Although these approaches can account for tissue 
stretching and motion artifacts, they are too computationally intensive for video-rate 
implementation and are carried out post-procedure. Therefore the clinician does not have 
the benefit of live evaluation of a large FOV. Another approach called real-time video 
mosaicing computes a simpler rigid registration in order to build the mosaic as each 
frame is acquired. This provides the user immediate feedback about broad tissue 
morphology, aids in maintaining probe stability, and helps create a better video for 
additional off-line processing. The concept was discussed for a commercial confocal 
system in proceedings [51] and was briefly mentioned in [52]. Unfortunately, neither of 
these publications provides a thorough description of a real-time video mosaicing 
algorithm.  
In this chapter we present an algorithm and initial results for real-time in vivo 
video mosaicing. The technique is implemented on an inexpensive high-resolution 
microendoscope (HRME). Compared to commercial microendoscopes that can cost > 
$50,000, the HRME (< $5,000) enables access to a greater number of researchers and 
clinicians. The algorithm is a three step process that includes: fiber bundle pattern 
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removal, image registration, and insertion into a mosaic. Mosaic results are compared to 
benchtop confocal imaging as well as histopathology. To the best of our knowledge, this 
is the first publication to provide a complete description and histopathology comparison 




4.2.1. High-resolution microendoscope (HRME) 
The system that we modified for real-time video mosaicing was previously used 
in several in vivo tissue studies [53, 54]. It is well-suited for animal experiments and 
clinical applications because it is small, portable, battery-powered, and interfaces with a 
standard laptop computer (see Figure 4-1A). Although the system is thoroughly described 
in [55], we provide a brief description of the device here.  
Figure 4-1: (A) The high-resolution microendoscope (HRME) is a portable fluorescence 
imaging device that provides in vivo subcellular detail with a field-of-view of <1 mm. 
(B) Real-time video mosaicing increases the field-of-view. 
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The HRME is a widefield epi-fluorescence fiber-bundle microendoscope. It uses a 
5W 455 nm light emitting diode (LED) and lenses to provide Koehler illumination at the 
proximal face of a 30,000-element coherent fiber bundle. The tissue at the distal end of 
the fiber bundle is labeled with the fluorescent dye proflavine, which binds to DNA and 
has a peak emission of 515 nm. Emitted light exiting the proximal end of the fiber bundle 
passes through a dichroic filter and a longpass filter. It is then imaged onto a CCD using a 
10X objective and tube lens. Images are acquired at a rate of 11 frames per second (FPS) 
at 16-bit digitization. Camera settings, image display, and file saving are controlled with 
custom LabVIEW software. Figure 4-2 (left) shows a raw image of nonkeratinized 
stratified squamous epithelium acquired by the device. Nuclei appear as bright circles 
throughout the image and individual fibers within the fiber bundle can be seen.  
4.2.2. Fiber pattern rejection 
The first step to implement video mosaicing is to remove the fiber bundle pattern 
from HRME images. This is necessary because the fixed spatial frequencies produced by 
the bundle structure hinder the subsequent image registration algorithm. For real-time 
video mosaicing a fast, accurate, and memory efficient method is necessary. Ideally, this 
step should run much faster than the HRME’s nominal operational speed of 11 FPS. A 
few publications discuss methods to remove the bundle pattern while preserving image 
content, including: spectral filtering in the frequency domain [56], median filtering in the 
spatial domain [57], or spatial interpolation [58]. We developed a custom spatial 
interpolation algorithm because none of these methods were tailored for real-time 
 32  
 
execution. Based on the nearest-neighbor lookup table method suggested in [58], our 
approach (1) preserves all intensity information of the sample image and (2) requires 
minimal computation time and memory.  
The nearest-neighbor interpolation algorithm reconstructs an image based on 
pixel intensities at regional maxima. As shown in Figure 4-2 (right, “Raw Image”), fiber 
cores appear as regional maxima within the images due to the Gaussian intensity profile 
that they create on the detector. The pixel values at the center of these regional maxima 
best represent the intensity of the underlying object; therefore we use only these values to 
reconstruct a fiber-less image. First, fiber center pixels f are determined using the Matlab 
regional maxima function imregionalmax.m described in [59] (see Figure 4-2 “Fiber 
Locations”). Next, for each image pixel location p = (xp, yp), an enclosing triangle of 




݀(܎૜)ቍ = 	 ቆݔଵ ݔଶ ݔଷݕଵ ݕଶ ݕଷ1 1 1 ቇିଵ ൭ݔ௣ݕ௣1 ൱  .   (1) 
The intensity of p is then chosen by selecting the nearest fiber fn: 
I(p) = I(fn)  .      (2) 
The Matlab functions griddata.m and TriScatteredInterp.m are used to compute 
the Voronoi tessellation (see Figure 4-2 “Nearest-Neighbor Tessellation”). For real-time 
implementation, we assume that the fiber bundle pattern remains fixed within a sequence 
of images. Therefore, the tessellation is computed only once at the beginning of the 
procedure to determine a lookup table of fiber core reference coordinates. The lookup 
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table is calculated from an image of a uniform fluorescent slide (Fluor-Ref Green, Ted 
Pella). Subsequent HRME image are then divided by this “calibration” image to 
normalize the fiber bundle intensity response. In addition, given that fibers are spaced 
approximately 5 pixels apart, we found that downsampling the lookup table by a factor of 
2 – 3 also reduces processing time while maintaining image quality. Applying the lookup 
table to raw a 1.3 megapixel HRME image takes 0.8 ms on our laptop computer (Intel i7-
2720QM), as shown in Table 1. The interpolated and downsampled result is 
Figure 4-2: Fiber pattern removal. (Left) The raw HRME image shows squamous 
epithelial cells in the oral cavity. Nuclei are labeled with 0.01% Proflavine. The intensity 
information from the sample is “pixelated” by the 30,000-element fiber bundle. (Right) 
The fiber pixelation pattern is removed using two-dimensional interpolation. First, the
fiber center locations are identified using a regional maxima function. A Voronoi 
tessellation is then constructed from these points in order to determine the nearest-
neighbor fiber pixel for every non-fiber pixel. A lookup table is determined from this 
tessellation and is used to reconstruct fiber-less HRME images in real-time. Other 
interpolation methods, such as bilinear interpolation, can be used but have longer 
computation times.  
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approximately 375 x 375 pixels. Figure 4-2 (“Nearest-Neighbor Interpolation”) shows 
our fast interpolation method removes the fiber pattern while preserving image edges and 
contrast.  
4.2.3. Frame registration 
The registration algorithm determines the best translational offset between two 
consecutive video frames and calculates an error for their fit. Before registration, a 
rectangular region of interest is cropped from the circular FOV of processed HRME 
images. This prevents registration errors caused by fiber bundle edges. Time and memory 
constraints for registration are the same as for the interpolation algorithm. For this reason, 
we chose to implement the fast registration algorithm presented in [60], which performs 
an optimized cross correlation using discrete Fourier transforms (DFTs). The cross 
correlation of two images f(x,y) and g(x,y) is given by: 
ݎ௙௚(ݔ௜ ,ݕ௜) = 	 ∑ ܨ(ݑ,ݒ)ܩ∗(ݑ, ݒ)݁ݔ݌ ቂ݅2ߨ ቀ௨௫೔ெ + ௩௬೔ே ቁቃ௨,௩   , (3) 
where N and M are the image dimensions, uppercase letters represent the DFT, 
and (*) denotes complex conjugation. The approach to finding the cross-correlation peak 
is to (i) compute the product F(u,v)G*(u,v), (ii) take the inverse FFT to obtain the cross 
correlation, and (iii) locate its peak [60]. Error of registration fit is given by the 
normalized root-mean-square error (NRMSE). On average we found the registration 
algorithm is executed in 12.2 ms (see Table 1).     
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4.2.4. Frame insertion 
Registered HRME frames are inserted into a large zero-value image called a 
canvas. The canvas size is selected by the user and is typically 1 to 7 MP, which is 7 to 
50 times larger than a downsampled HRME frame. The first frame in a video sequence is 
copied to the center of the canvas. Subsequent frames are inserted into the canvas at an 
offset determined by the registration algorithm. We tested two real-time insertion 
strategies: (i) pixel maxima and (ii) dead leaves.  
 
The pixel maxima approach inserts the maximum intensity value for each 
overlapping pixel of the newest frame and current mosaic. This strategy works well for 
more rigid tissue such as epidermis, but results in a motion-blurred mosaic when used on 
Figure 4-3: The HRME was translated over fluorescently-labeled lens paper to build a 
mosaic. (A) When video frames are inserted into the mosaic using the pixel maxima 
approach, frame boundaries are smooth, but disturbed fibers appear blurred as shown by 
the arrows. (B) When the dead leaves approach is used, blurring does not occur, but 
frame boundaries can become noticeable. The dead leaves approach is preferred for 
tissue imaging because probe movement significantly deforms the tissue.  
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deformable tissue or targets with free-moving debris. For our application it is important 
to preserve size and separation of features such as nuclei, so we typically use the dead 
leaves approach [51], which simply replaces overlapping regions with the new frame. 
Figure 4-3 shows mosaicing results from fluorescently-labeled lens paper using each of 
these techniques. Although individual frame boundaries can become apparent when using 
the dead leaves approach, spatial features within the image maintain their size. To reduce 
frame boundary visibility when the probe is moving slowly, we only insert frames that 
have moved at least one tenth of a FOV from the last inserted frame.  
4.2.5. Error handling and file saving 
Registration errors can occur for several reasons. First, registration errors can 
result from motion blurred images. This is prevented by selecting a low camera exposure 
(< 10 ms) and by translating the probe slowly across the tissue. Slow translation also 
ensures that consecutive frames have overlapping spatial features to register. We found 
registration works well when consecutive frames have at least 75 percent overlap, which 
corresponds to a maximum velocity of 2.75 mm/s for a 1 mm HRME probe imaging at 11 
FPS. Registration errors can also occur when there is little spatial information (such as in 
uniform gray images) or when there is loose debris. The NRMSE is used to determine if a 
registration has occurred. Frames with NRMSE error above 0.5 were considered 
misregistered. In general, we often found that small spatial discontinuities from 
misregistered frames did not significantly degrade the overall quality of the mosaic (see 
Figure 4-4D). Therefore, instead of restarting the mosaic after a registration error, the 
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misregistered frames can alternatively be highlighted and inserted into the current 
mosaic. As an indicator of the probe moving too quickly, we also chose to highlight 
frames that overlap less than 75% with the previous frame. 
Although the canvas is displayed in real-time, it is impractical to save every frame 
of the reconstructed mosaic because of the large canvas size. Instead, we allow the user to 
save snapshots of the mosaic or save a movie of the raw camera data. Mosaic snapshots 
are saved as 16-bit .png images and movies are saved as two 8-bit .avi videos, which 
contain the high and low bits of 16-bit frames.   
4.3. Results 
All steps of the video mosaicing procedure were implemented and benchmarked 
in a real-time LabVIEW graphical user interface (GUI) on a standard laptop computer 
(Intel i7-2720QM). A summary of the computational time requirements for our real-time 
video mosaicing algorithm is shown in Table 4-1. The first row shows the execution time 
with no mosaicing, which represents time to read the image buffer and display the image. 
Times for fiber rejection and frame registration remain constant because these are only 
dependent on the raw image size. However, frame insertion time is dependent on the total 
empty mosaic size; therefore, the results are shown for several canvas sizes. In all cases 
the execution time of the mosaicing GUI is faster than the frame rate of the camera 
(which has a maximum speed of 11 FPS or 91 ms/frame).  
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Real-time video mosaicing was tested on several ex vivo and in vivo tissue specimens. 
All data collection followed IRB approved protocols (Rice University 11-119E and MD 
Anderson Cancer Center PA11-0570). Figure 4-4 shows video mosaics obtained in vivo 
from the (A) lower lip and (B) skin of a normal volunteer, which demonstrates the 
algorithm performs well on different cell types. In these examples video mosaicing 
increased the FOV 3-10 times. Our microendoscopy mosaicing results reveal similar 
morphological features, such as hair strands and keratin sheaths, as a skin mosaic 
obtained from a commercial benchtop confocal microscope (Figure 4-4C).  In Figure 
4-4D we present video mosaicing results from an ex vivo cervical “loop electrosurgical 
excision procedure” (LEEP) specimen. The HRME probe was scanned from normal 
squamous tissue to abnormal columnar tissue (shown by the white arrow), which in this 
case represents the border of diseased tissue. Determining this boundary is more difficult 
with the limited FOV of a single HRME frame, but is clearly defined in the mosaic result. 
Figure 4-4E shows a histology section from the same boundary region. Throughout 
Table 4-1: Time requirements for the video mosaicing algorithm. 
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imaging experiments real-time mosaicing provided immediate feedback about probe 
stability and velocity, which is important when additional offline processing is desired.  
 
Figure 4-4: Real-time video mosaics from (A) normal in vivo oral tissue, (B) normal in vivo epidermis, and 
(D) cancerous ex vivo cervical tissue. These results show that the algorithm correctly aligns and combines 
morphological features of several cells types and anatomical locations. In (A) the distribution of normal 
squamous epithelial cells is seen in the gingiva and in (B) features such as hair and keratin sheaths are 
visible. An image mosaic (C) from a benchtop confocal microscope obtained during the same imaging 
session reveals similar morphologic features as (B). The normal/abnormal junction of ex vivo cervical 
tissue is shown (D), where the white dotted line indicates the path of two mosaics. The bottom mosaic in 
(D) shows that it can be useful to display a large mosaic even with several misregistered/blurred frames 
(white arrows). Histopathology for the cervical tissue normal/abnormal junction is shown in (E). 
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4.4. Discussion 
In this chapter we describe a complete algorithm for real-time video mosaicing 
using a portable low-cost high-resolution microendoscope. The algorithm is executed on 
the laptop computer’s CPU well within the nominal frame rate of the camera. Speed 
could be further improved with the use of GPU programming, which can take advantage 
of parallel architecture and massive multithreaded data processing. While our technique 
provides accurate mosaics in many imaging applications, as shown with ex vivo and in 
vivo samples, there are several inherent limitations to the technique. There must be (1) 
spatial features within consecutive images, (2) spatial overlap between consecutive 
images, (3) minimal free-moving debris, and (4) minimal tissue deformation. These 
requirements could be prohibitive for some endoscopic cases, such as deep tissue where it 
may be difficult to slide the probe across the tissue or locations with significant debris.   
The solution to these limitations could be to use a two-step mosaicing strategy 
which involves (1) real-time mosaicing for live image acquisition and (2) post-procedural 
mosaicing for higher accuracy reconstruction. With post-procedural mosaicing there is no 
strict time requirement, which allows for techniques such as non-rigid image registration 
and template matching. These algorithms can overcome the limitations of real-time 
mosaicing because they can selectively ignore potential debris, deform images before 
registration, register images based on their best fit within an entire mosaic, and blend 
overlapping images. 
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Our current work on video mosaicing provides a live picture of broad tissue 
morphology (> 5 mm2) using a < 1 mm diameter microendoscope probe. Future work 
aims to implement post-procedural mosaicing with the HRME and to develop algorithms 
to automatically quantify features such as nuclear-to-cytoplasmic ratio and nuclei spacing 
within mosaics. These new techniques will then be used to test the diagnostic value of 
HRME video mosaicing for several cancer types in multi-center clinical trials.  
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Chapter 5 
Increasing lateral resolution of 
endomicroscopes: snapshot spectrally 
encoded fluorescence imaging*  
*The contents of this chapter were submitted to a journal as the following manuscript: N. Bedard, and T. Tkaczyk, 
"Snapshot spectrally encoded fluorescence imaging through a fiber bundle endomicroscope," Journal of biomedical 




Another drawback of current configurations for endomicroscopes is that they have 
either limited spatial resolution or require a scanning mechanism at the distal end of the 
fiber, which can slow imaging speed and increase the probe size. We present a novel 
configuration that provides high contrast 350 x 350 pixel images at 7.2 frames per 
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second, without the need for mechanical scanning at the proximal or distal end of the 
fiber. The device is tested in fluorescence mode and can resolve 1.5 µm features of a 
high-resolution 1951 USAF target.  
5.1. Introduction 
Endomicroscopy is an important tool for minimally invasive diagnosis and 
surgery as well as in vivo cellular research in animal models. Small and flexible fiber 
optic endomicroscopes with < 1 mm outer diameter have been built by utilizing optical 
fibers that transmit an image to a light detector outside of the body. Although fibers 
enable a small distal probe size and microscopic field-of-view, the image quality and/or 
frame rate is reduced as a consequence of the fiber-dependent optical system.    
Several configurations for fiber optic endomicroscopes have been shown [45]. A 
common implementation uses a coherent bundle of optical fibers as an image guide. 
Some confocal and multi-photon fiber bundle systems illuminate one fiber at a time with 
a pair of raster-scanning mirrors while a point-detector such as a photo-multiplier tube 
(PMT) detects returning light [61-63]. Alternatively, a two-dimensional detector array 
can be used to capture an image in a single exposure. This configuration can have 
reduced cost, size, and optical complexity [53, 54]. In addition, it can take advantage of 
modern scientific-grade camera technologies such as sCMOS, EMCCD, or back-thinned 
sensors that provide higher speed, greater quantum efficiency, lower noise, and more 
sampling than with a scanning-type system [64]. When using a fiber bundle, however, the 
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quantity of optical fibers that can be packed into the bundle (usually ~5000 to 30,000 
fibers) limits the number of spatial samples, and therefore limits the resolution of images 
being displayed [65].  
Some endomicroscopes avoid this limitation by using a single optical fiber 
coupled to a two-axis mechanical scanner at the sample plane. High-speed scanning 
systems are difficult to miniaturize, therefore these systems sacrifice frame rate and probe 
size for improved image quality [66, 67]. Another single fiber technique, known as 
spectrally encoded endoscopy (SEE), replaces mechanical scanning in one dimension 
with a prism and a broadband light source in order to create a line of spectrally dispersed 
light on the sample [68, 69]. Spectrally encoded spatial information can be detected with 
a line-spectrometer at the proximal end of the fiber, which reduces the size and 
complexity of the distal system. The technology, however, still requires one axis of 
mechanical scanning and is difficult to implement in fluorescence imaging mode due to 
the Stokes shift of fluorescent contrast agents [70].  
In this chapter, we present a novel endomicroscope configuration that combines 
the benefits of using a fiber bundle with the increased sampling of spectral encoding. To 
the best of our knowledge, this is the first demonstration of increasing lateral resolution 
in a fiber bundle endomicroscope without the need for moving parts in the system. The 
configuration is well suited for miniaturization because no electronics or mechanics are 
required at the distal end.  
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5.2. Methods 
The concept that we call snapshot spectrally encoded endomicroscopy (SSEE) is 
illustrated in a fluorescence imaging configuration in Figure 5-1A. The setup uses an 
optical system at the distal end of the N-element fiber bundle in order to sample the 
fluorescent object at different spatial offsets. Figure 5-1B shows spatial offsets are from 
lateral chromatic shift induced by dispersion of a prism. The fiber bundle samples the 
dispersed image at spatial offsets that correspond to different emission wavelengths. 
Once spatial information is spectrally encoded into the fiber bundle, a hyperspectral 
camera captures the offset spectral images at the proximal bundle face. Spectral images 
are combined into a single high-resolution image using a custom reconstruction 
algorithm. This series of steps registers the spectral images that have been offset by 
dispersion, determines the intensity information contained at each fiber core within the 
spectral images, and then combines all of the sampling information into a single image. 
The algorithm includes (1) fiber bundle pattern removal (2) image registration and (3) 
combination of spectral images. Using this reconstruction procedure, the N spatial 
samples from each of the M spectral image are combined into a single image with N x M 
spatial samples (see Figure 5-2). The increase in sampling improves the image resolution 
without the need for any scanning mechanism in the system.  
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Our previous studies used a traditional fiber bundle endomicroscope configuration 
to detect size and distribution of cell nuclei within potentially cancerous tissue [53, 54]. 
In the proof-of-concept system presented here, we aimed to improve visibility of 
subcellular features using snapshot spectral encoding. The fluorophore proflavine is used 
to stain nuclei and has an emission full-width half-maximum (FWHM) over the range 
515 – 570 nm. In order to increase fiber bundle sampling of the fluorescent object, we 
chose to match the dispersion range of the emission spectrum to a distance comparable to 
Figure 5-1: Snapshot spectrally encoded endoscopy concept. (A) A prism and lenses are 
attached to the distal end of a coherent fiber bundle. The image of the sample is dispersed 
over the face of the bundle, which causes the discrete fibers to sample the image at 
slightly different offsets. Using a reconstruction algorithm, the fiber samples from each 
wavelength are combined to produce one image with higher contrast and resolution. (B) 
In a traditional fiber bundle imaging system, the number of spatial samples is limited by 
the amount of fibers within the bundle. Our configuration uses dispersion to overcome 
this sampling limitation. A hyperspectral camera captures the encoded images. 
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the fiber spacing (see Figure 5-1B). This was achieved with two infinity-corrected 10X 
Olympus objectives mounted in an afocal 4-f imaging configuration with a 6o wedge 
prism placed in between. Excitation and emission light were separated with a FITC filter 
set. The system also included a Mercury arc lamp that delivered excitation light through 
the 6,000-element S-Type Fujikura fiber bundle. A snapshot hyperspectral camera called 
the Image Mapping Spectrometer (IMS) was used for image detection [71]. This detector 
was selected because it collects all spatial-spectral information in a single camera 
exposure and has high light efficiency; therefore it can detect low fluorescence signals 
and does not suffer from motion artifacts of scanning-type hyperspectral cameras. It has 
also been used in other endoscope configurations [72]. The IMS acquires 350 x 350 
spatial x 20 spectral samples within the range 515 – 570 nm, at 7.2 frames per second 
(FPS) and 12-bit digitization. Thus, datacubes contain ~6,000 fiber x 20 spectral-encoded 
measurements, which correspond to 120,000 unique spatial samples; this improvement in 
sampling is comparable to increasing a 70 x 70 pixel image to a 346 x 346 pixel image.  
The system is calibrated with a high-resolution 1951 USAF resolution target 
(Edmund Optics) backed with a Fluor-Ref green fluorescent slide (Ted Pella). After 
recording a datacube of the resolution target, the calibration starts by removing the fiber 
bundle pattern from each spectral image. This step is required because the fiber bundle 
pattern would otherwise interfere with registration of spectral images. The pattern is 
removed by implementing the interpolation method described in [58]. This method first 
identifies the pixel at the center of each fiber core, because these pixels best represent 
intensity values from the object. Pixel locations are determined using the Matlab regional 
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maxima function imregionalmax.m described in [59]. Next, pixels around identified fiber 
cores are filled using a fast two-dimensional linear interpolation [58]. The result of 
interpolation for one spectral image is shown within Figure 5-2A.  
 
 
Interpolated spectral images are then registered. The purpose of registration is to 
determine the horizontal and vertical subpixel spatial offset of each spectral image. The 
magnitude/direction is dependent on the dispersion introduced by the prism. Images with 
fiber pattern removed are intensity normalized and then registered with the FFT 
Figure 5-2: SSEE calibration procedure. (A) A datacube of a high resolution 1951 USAF 
target is acquired. The fiber bundle pattern is removed from each spectral image using 
interpolation based on fiber core centers. Spectral images are then registered. All spectral 
images are combined by taking the maximum fiber core intensity at each image 
coordinate. Effectively, void spaces between fibers in one spectral image are filled with 
fiber core intensity from other spectral images. Any remaining void spaces are filled with 
interpolation. (B) The results of SSEE show improved resolution and contrast compared 
to a fiber bundle image without spectral encoding.  
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algorithm described in [60]. Next, core locations from each coregistered spectral image 
are combined into a single image. This process essentially fills void spaces between 
fibers core in an image with information from fiber cores of other spectral images. 
Intensity values at all core locations are combined using a maxima function, 
 
Iall(p) = max{ Iλ=1(f), Iλ=2(f), … , Iλ=M(f)}  .  (1) 
 
where Iall is the image containing all fiber core information from M spectral 
images Iλ. Finally, any remaining void space is filled using the previously described 
interpolation method. 
5.3.  Results 
Figure 5-2B shows the SSEE calibration result compared to the fiber bundle 
endomicroscope with no spectral encoding. An increase in resolution is apparent from the 
zoomed sections. Group 8 Element 3 (1.5 µm/line) can be partially resolved for the SSEE 
result, whereas the bundle system with no spectral encoding resolves up to Group 7 
Element 3 lines (3.1 µm/line). The SSEE image also has increased contrast. The 
achievable resolution is dependent on the performance of the distal optics, the pseudo-
regular spacing of fibers within the bundle, the reconstruction algorithm, and the pixel 
quantity on the detector. 
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After the 
calibration, all subsequent 
spectral images taken with 
the SSEE are combined 
using the same fiber 
locations and spatial offsets 
determined in the 
calibration procedure. 
Figure 5-3 shows images of 
(A) lens paper and (B) in 
vivo epithelial cells from the 
lower lip of a normal 
volunteer acquired at 7.2 
FPS, with and without 
snapshot spectral encoding. SSEE images contain higher contrast, and details such as 
nuclear shape and cell membranes are more clearly visualized.  
5.4. Discussion 
This report describes a novel configuration for a microendoscope device that can 
be used to obtain high quality images with no scanning mechanism required at the 
proximal or distal end. Implementation of the modality has only recently become possible 
Figure 5-3: (A) Lens paper and (B) in vivo epithelial 
tissue from a normal volunteer’s lower lip stained with 
proflavine.  Snapshot spectrally encoded images have 
higher contrast and resolution, which increases visibility 
of details such as cell nuclei and membranes.  
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due to advances in real-time, high-throughput snapshot hyper- and multi-spectral imaging 
technology. Other distal optics with different types of lateral chromatic distortion can be 
used to offset spatial sampling, such as holographic diffraction gratings, or GRIN lenses 
that have inherent radial lateral chromatic aberration [73]. Future work aims to improve 
imaging performance and decrease the size of distal optics using in-house techniques for 
fabricating miniature optics [74]. 
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Chapter 6 
Improving depth-sectioning and 
background rejection of 
endomicroscopes: confocal and 
structured illumination 
As shown in Chapters 3, 4 and 5, microendoscopes allow clinicians to view in 
vivo subcellular features in real-time, which can enable point-of-care diagnosis of 
dysplasia and cancer. While imaging studies have shown high sensitivity for diagnosing 
epithelial cancers, there are some tissue sites and conditions where it is difficult to 
visualize and quantify diagnostic features. In these cases a device with axial response of 
< 50 µm is typically needed to view features obscured by tissue debris and/or reject out-
of-focus background signal. Commercial confocal microendoscopes with excellent axial 
response are available, but are often cost-prohibitive for many researchers and clinicians. 
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In this chapter, we present two low-cost (< $10,000), compact, and user-friendly 
endomicroscope systems with < 50 µm axial response. These devices also serve as a 
platform for our custom high-NA microendoscope objectives, which provide greater 
lateral resolution and the ability to image beneath the tissue surface.  
6.1. Introduction  
Microendoscopes allow clinicians to view in vivo subcellular features in real-time, 
which can enable point-of-care cancer detection of dysplasia and cancer [45]. In our 
research setting, we use a device called the High Resolution Microendoscope (HRME) to 
inspect epithelial tissues for precancer. The HRME is a fluorescence imaging device that 
uses the contrast agent proflavine to label DNA molecules [53, 55]. When acquiring 
images of stained epithelial tissue, proflavine causes nuclei to appear as bright circles 
throughout the field-of-view (FOV). Using imaging processing algorithms, we can 
quantify features such as nuclear-to-cytoplasmic ratio and nuclear separation in order to 
estimate disease probability. While studies have shown the HRME’s ability to detect oral 
epithelial cancers [54], there are some tissue sites and conditions where it is difficult to 
visualize and quantify nuclear features. 
The HRME has been proven as an effective tool for detecting epithelial cancers in 
the oral cavity, because several conditions are met: (1) most tissue is non-keratinized; (2) 
the stratified squamous epithelium cell type contains relatively large nuclei; and (3) 
proflavine is lightly sprayed or swabbed onto the tissue. However, the HRME does not 
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perform as well in other conditions. For example, it cannot accurately diagnose highly 
keratinized tissue because keratinocytes nonspecifically uptake proflavine. Fluorescing 
keratin sheaths often saturate the detector and prevent imaging of underlying nucleated 
cells, which makes it difficult to quantify nuclear features indicative of cancer. In tissue 
types other than stratified squamous epithelium, such as glandular epithelium, cells can 
become smaller and more crowded. Sometimes the cells become smaller than the HRME 
can laterally resolve; or they can become crowded in the axial direction, which increases 
background and reduces image contrast. These effects make it difficult to quantify 
nuclear features. Finally, in many ex vivo imaging protocols, the tissue is submerged in 
proflavine rather than sprayed/swabbed. While this procedure is intended to provide 
uniform labeling for supplemental widefield imaging, it has the consequence of adding 
significant fluorescent background to HRME images. Overall, there are several 
circumstances where bright features in the foreground (keratin) or background (cells or 
excess proflavine) prevent successful quantification of nuclear features within HRME 
images.  
In this chapter, we present strategies to address current imaging limitations. We 
describe and implement two HRME modifications to improve depth sectioning, contrast, 
and background rejection. In order to facilitate translation into clinical studies, the 
solutions are compact, low-cost and user-friendly. Results for the original HRME system 
and our modified systems are compared with standard testing targets as well as ex vivo 
and in vivo specimens. Finally, we use these devices to image with a custom high-NA 
microendoscope objective.  
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6.2. Methods 
Our solution to decrease unwanted foreground/background signal in HRME 
images is to improve axial response. Axial response is a measure of both axial resolution 
and the ability to reject light from outside the focal plane. A system with small axial 
response is able to reject fluorescence emitted from out-of-focus planes, which 
effectively decreases background and increases contrast when imaging thick specimens. 
Additionally, small axial response allows a microendoscope to image axial sections 
beneath the tissue surface, also known as depth sectioning. The current HRME system 
has an axial response of several millimeters because there is no mechanism for depth 
sectioning.  Our previous studies have shown the ideal axial response for imaging 
glandular tissue is < 30 µm. Another study showed that a single axial section 50 µm 
below the tissue surface can be used to delineate normal, dysplastic, and cancerous tissue 
[75]. In this section we describe two modalities that are used to improve axial response in 
our endomicroscope studies: structured illumination (SI) and confocal microscopy. We 
provide the background for each of these techniques as well as details of our 
implementation.  
6.2.1. Confocal HRME 
Confocal microscopy is a common technique used to collect thin optical sections 
of a tissue sample. It works by scanning a diffraction-limited point of light throughout the 
focal plane of the sample, while detecting returning light through a pinhole aperture 
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placed at a conjugate image plane [62]. This method blocks out-of-focus light and can 
have axial response < 1 µm. Instead of using an LED and CCD detector as in the HRME, 
it requires mechanical scanners, a coherent laser source, and a high speed point-detector 
such as a photomultiplier tube (PMT). Although confocal endomicroscopy has been 
demonstrated on several fiber-bundle systems with promising clinical results [48, 61, 62], 
current commercial systems are often too expensive for many researchers and clinicians. 
In this work we developed a confocal fluorescence fiber bundle endomicroscope that is 
compact, low-cost, and user-friendly.  
 
 
We were able to create a compact low-cost device, comparable to the current 
HRME systems by: (1) creating custom-designed plastic optomechanics with the use of a 
Figure 6-1: A drawing of the confocal HRME is shown in (A). A schematic of the device 
as well as optical/acquisition calculations are shown in (B). 
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rapid prototyping machine, (2) using consumer grade optics, (3) using miniature scanning 
galvanometer mirrors, (4) utilizing a high-power handheld laser pointer, and (5) 
synchronizing all hardware/signal control with a USB device. The cost of the complete 
system is less than $10,000. Figure 6-1 shows a CAD drawing and schematic for our 
device. The size of the confocal device compared to the HRME is shown in Figure 6-2.  
 
The optical train of the device starts with the handheld laser pointer (Wicked 
Lasers Arctic III). Using consumer optomechanics (Thorlabs) the laser output beam (1 W 
455 nm) is coupled into a single mode optical fiber. This acts as a spatial filter that 
creates a diffraction limited point of excitation light. Filtered laser light is then collimated 
and redirected with a dichroic mirror (Semrock). Next, the collimated beam of light is 
raster scanned over the proximal face of the fiber bundle using two synchronized closed 
loop galvanometers (Cambridge Technologies), a scan lens, and a finite-conjugate 10X 
objective (Edmund Optics). Emitted light returning from the fiber bundle passes through 
the same scanning optics, the dichroic mirror, and is focused onto a pinhole. A 
photomultiplier tube (Hamamatsu) placed behind the pinhole converts collected photons 
into an analog voltage signal, which is read by the USB data acquisition device (NI USB-
Figure 6-2: Drawings of the HRME (right) and confocal-HRME are shown. The overall 
dimension of the devices are comparable.  
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6363). Finally, a custom LabVIEW program transforms the signal into an image and 
displays the result in real-time on a laptop computer. The software also provides user 
controls for file saving, PMT gain, imaging speed, and frame size.  
 
A key to our device’s small size and simplicity is complete optomechanical 
synchronization through one electronic component. While other scanning systems can 
require separate cards for the frame grabber, timing electronics, and scanning signals, we 
use a single USB data acquisition device for all signal operations. This component can 
acquire 2 million samples per second on one input channel and can send 2.86 million 
Figure 6-3: The custom software for the confocal HRME. 
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samples per second on four output channels. We use two output channels to control the 
raster position of the two scanning galvanometers (see Figure 6-3) and another output 
channel to control the gain (sensitivity) of the PMT. Using the same timing clock, we 
read in the PMT voltage for each point within the scan. An image is then reconstructed 
by plotting consecutive PMT values at the respective x-y scan coordinates. The frame 
rate of the device is inherently limited by the maximum velocity of the scanning mirrors. 
In our optical configuration the x-scan mirror can raster scan at a rate of 1 kHz, which 
corresponds to 2000 forward/backward lines per second. Therefore, we could record a 
1000 x 1000 image at 2 frames per second (FPS), a 500 x 500 image at 4 FPS, or a 250 x 
250 image at 8 FPS. In order to stretch this limitation, we developed a custom scanning 
method that scans only the circular area of the fiber bundle. This is accomplished by 
circle modulating the x-scan, as shown in Figure 6-4. The method increases sampling at 
Figure 6-4: A standard raster scan is shown in blue. A circle-modulated x-scan (red) is 
used so that the laser only scans the fiber bundle surface. Reduced dwell time increases 
sampling/resolution and light efficiency. Reduced scan amplitude at the top and bottom 
of the FOV also allows the mirror to run faster, which increases frame rate. 
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the edges of the fiber bundle, increases dwell time and light collection, and reduces the 
average amplitude of the scan. By reducing stress on the fast x-scan mirror, we are able to 
increase imaging rate to 500 x 500 at 5 FPS or 250 x 250 at 10 FPS. Our custom software 
then uses a high-speed interpolation algorithm to create an image from the circular scan 
pattern, as shown in Figure 6-5.  
 
The expected optical and acquisition parameters for our system is shown in Figure 
6-1 (right). Lateral and axial resolution is dependent on the objective NA and emission 
wavelength. In our system the theoretical lateral resolution is < 1 µm at the proximal face 
of the fiber bundle, but is typically limited by the chosen sampling configuration. For 
example, a 1 mm2 object sampled by 500 x 500 points will have a lateral resolution of 4 
µm according to the Nyquist sampling theorem. This is just enough to resolve the fiber 
Figure 6-5: Raw data is read into an using a USB DAQ. The one dimensional array is 
reshaped into a two-dimensional image, which represents the concatenated forward and 
backward scan of the circle-modulated raster scanning mirrors (A). The image is then 
resampled to reconstruct linear sampling coordinates of the sample (B). Finally, the two 
images are interleaved to form the true image (C). The final image is reconstructed in 
real-time using the custom LabVIEW interface.   
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bundle pattern, which has 3 – 4 µm fiber spacing. The theoretical axial response is 18 
µm. By translating a mirror through the focal plane of the objective lens, we determined 
the full-width half-maximum axial response of the system to be 25 µm, which is also a 
common experimental approximation for axial resolution. Using a fiber bundle with a 
distal high-NA miniature objective improves this value.   
6.2.2. Structured Illumination HRME 
Another method for improving axial response is structured illumination (SI). This 
technique works by imaging a known sinusoidal pattern onto the focal plane. Using a 
reconstruction algorithm, it extracts spatial frequency information from the modulated 
image in order to reject out-of-focus light. Conventional SI requires frequency-modulated 
images of the sample at three phase positions [76].  The method has been demonstrated in 
commercial microscopes, in fiber-bundle microendoscope systems, and used for clinical 
imaging [77]. The benefit of this technique for our application is that it uses most of the 
same hardware as the current HRME system, including the CCD camera and LED 
illumination. Possible disadvantages of the technique are (1) possible grid pattern 
artifacts when moving the quickly over the tissue and (2) low dynamic range and high 
noise when there is significant background signal or in thick specimens [78]. 
We were able to create a compact and user-friendly structured illumination 
microendoscope by (1) using the current compact HRME optical setup, (2) utilizing a 
small high-precision motorized translation stage, and (3) implementing 
hardware/software synchronization in a custom LabVIEW interface. Similar to the price 
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of the confocal endomicroscope system, the structured illumination HRME costs < 
$10,000. A schematic for the device is shown in Figure 6-6.  
 
Our structured illumination setup adds only a 10 lp/mm grid (Thorlabs), a 
condenser lens, and a motorized stage (Zaber) to the existing HRME setup. Using a 
custom LabVIEW program we synchronize grid movement and image acquisition, 
display the sectioned image, and provide user controls for exposure, gain, and file saving. 
The final size of the system is comparable to the original HRME dimensions. Expected 
Figure 6-6: The optical train of the structured illumination HRME system. Drawing 
courtesy of Matt Kyrish. 
 63  
 
lateral resolution is equal to that of the original HRME (< 1 µm), whereas the axial 
response is dependent on the grid frequency. In our configuration, we expect an axial 
response of ~ 50 µm. Imaging speed is limited by the maximum frame rate of the camera, 
which is 11 FPS. We found the device performs best at 7.5 FPS, because this allows more 
settling time between motorized stage positions. Although the sectioned images are 
displayed with a lag of two frames, our real-time algorithm displays sectioned images at 
the frame rate of the camera.  
6.3. Results 
In this section we show imaging results from the confocal, structured 
illumination, and original HRME systems. Results are shown for standard optical testing 
targets such as lens paper, as well as ex vivo and in vivo tissue specimens. We also 
provide direct comparisons between systems and compare our results to commercial 
benchtop confocal devices. All samples were stained with 0.01% proflavine and imaged 
according to IRB protocols (Rice 11-119E and 08-95E). 
6.3.1. Confocal Imaging 
Figure 6-7 shows images of oral mucosa using the confocal microendoscope 
system without the fiber bundle attached. These images provide a baseline for imaging 
performance, because the pixelation effect from the fiber bundle will reduce object 
sampling and degrade image quality. Cell membranes and nuclei are clearly visible 
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throughout the field-of-view. A wide FOV of 2 mm2 was selected in order to indicate the 
maximum area that the system can image. This FOV is much larger than the < 1 mm2 
FOV needed to image the fiber bundle. 
 
 
After attaching the fiber bundle, the confocal HRME system was compared to the 
original HRME system and a commercial benchtop confocal system using an ex vivo 
mouse tongue specimen. Figure 6-8A/B are images acquired from the same field-of-view 
in the specimen. The confocal system has approximately 9X greater Michelson contrast 
than the original HRME image. Increased contrast allows cellular morphology and nuclei 
to be more easily visualized. Figure 6-8C shows an image from the same tissue specimen 
Figure 6-7: The imaging performance of the confocal HRME with no fiber bundle in 
place. (A) and (B) are images of stratified squamous cells from the lower lip of a normal 
volunteer labeled with proflavine.  
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obtained with a commercial confocal system, which further demonstrates the effect of 
increased lateral and axial resolution/response.  
 
 
Finally, confocal fluorescence images were acquired in vivo from the lower lip of 
a normal volunteer. Images were obtained at 6 FPS and 500 x 500 sampling. Results 
shown in Figure 6-9 indicate that resolution, imaging speed, and signal intensities are 
adequate for visualizing proflavine-stained nuclei in vivo. In addition, we found low 
background signal throughout our imaging experiments, which means there is improved 
axial response in thick tissue specimens compared to the HRME. Overall, ex vivo and in 
vivo imaging results suggest that our compact, low-cost technique for improving axial 
response in the HRME is a promising solution. 
Figure 6-8: Epithelium tissue from an ex vivo mouse tongue specimen was labeled with 
proflavine and imaged with a (A) conventional HRME, (B) confocal HRME, and (C) 
commercial benchtop confocal microscope.  The background in the conventional HRME 
image makes is difficult to visualize subcellular features. The confocal images have ~9x 
higher contrast.  
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6.3.2. Structured Illumination Imaging 
Figure 6-10 shows imaging results from ex vivo breast tissue. Results from the 
original HRME, structured illumination HRME, and a benchtop commercial confocal 
microscope (Lucid VivaScope 2500) were compared. We included images from the 
commercial confocal device to demonstrate the imaging quality that pathologist typically 
require for detecting cellular features indicative of cancer. It can be challenging to 
quantify cellular features in breast tissue using the original HRME because cells are small 
and crowded, and a high background signal is present (see Figure 6-10A). For example, 
the top row of Figure 6-10 shows images of a breast lobule, which contains small 
compact cells arranged in a glandular structure. These features are lost within the 
background signal of the original HRME, because there is no mechanism to block out-of-
focus light. Using devices with smaller axial response significantly reduces background 
signal and increases image contrast, which increases visibility of the glands and other 
Figure 6-9: Confocal microendoscope images from in vivo oral mucosa of a normal 
volunteer obtained with the system operating at 6 frames per second. Cells nuclei, 
membranes, and tissue architecture is clearly visualized. 
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features. Figure 6-10 (bottom row) shows an example of cancerous breast tissue. In this 
case and throughout our entire breast imaging experiment, we found improved axial 
response always increased visibility of cellular features. This is important for improved 
cancer detection by a pathologist or through automatic quantitative methods.  
 
 
Figure 6-10: Images of ex vivo breast tissue using (A) the original HRME, (B) the 
structured illumination HRME, and (C) a commercial benchtop confocal microscope. 
The top row shows images tissue from a lobule, which has small crowded nuclei and 
distinct glandular morphology. The bottom row shows images obtained from a tumor
specimen, which has small crowded nuclei with disorganized morphology. In both 
specimens the original HRME has high background signal and low contrast compared to 
the structured illumination HRME and commercial confocal microscope.  The devices 
with increased axial resolution can more clearly visualize cellular features, which can 
provide a more accurate diagnosis. Images acquired by Matt Kyrish and Jessica Dobbs.  
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6.3.3. Confocal/SI Comparison  
Finally, imaging results from the original, structured illumination, and confocal 
HRME were compared using fluorescently-labeled lens paper. We developed a 
convenient qualitative test that could be performed in our lab setting with all three 
devices. First, the distal end of a fiber bundle was placed in contact with lens paper using 
a translation stage. The proximal end was then attached to the HRME system and images 
were acquired, as shown in Figure 6-11A (top row). Next the proximal end was 
unattached and then coupled to the structured illumination system for imaging, as shown 
in Figure 6-11B. The same procedure was repeated for the confocal system in Figure 
6-11C. Using this procedure, the same FOV was imaged with each system, which allows 
direct comparison between modalities. Results show significant background reduction for 
both the structured illumination and confocal systems. In these images the structured 
illumination system also has higher contrast. For some specimens it is useful to image 
with higher lateral resolution by using a custom-made 3X miniature objective attached at 
the distal end of the fiber bundle. The additional optics can reduce the FOV and decrease 
light throughput. Therefore, we also compared imaging performance when using a 3X 
miniature objective. Figure 6-11 (bottom row) shows these results, which also 
demonstrate improved background rejection in the structured illumination and confocal 
systems. In these images the confocal HRME has higher contrast and less noise, because 
of the high power laser and high sensitivity PMT used in the system.       




In this chapter we presented compact, low-cost implementations of traditional 
structured illumination and confocal microendoscopes. Both systems exhibit improved 
axial response compared to the HRME used in our current clinical studies. They are an 
order of magnitude less expensive than commercial devices with comparable imaging 
specifications. In the future we will expand testing of custom-made high-NA 
Figure 6-11: Fluorescently-labeled paper was imaged with the (A) conventional HRME, 
(B) structured illumination HRME, and (C) confocal HRME. The top images show the 
performance of the system with no lens at the distal end; the bottom images were taken 
through a custom 3X  microendoscope objective.  
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microendoscope lenses. A custom distal lens will enable imaging below the tissue 
surface, closer to the basement membrane where epithelial cancers originate. This will 
allow earlier detection of cancer. When imaging through a distal objective, our HRME 
systems with improved axial response will be essential for blocking foreground intensity 
at the tissue surface. We believe these systems will become valuable tools for 
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Chapter 7 
Image mapping spectrometry: 
calibration and characterization* 
*The contents of this chapter were submitted to a journal as the following manuscript: N. Bedard, N. Hagen, L. Gao, 
and T. Tkaczyk, "Image mapping spectrometry: calibration and characterization," Optical Engineering (2012 ).  
While high resolution endomicroscopy is important to visualize subcellular 
morphology, a modality called spectral imaging can provide information about the 
biochemical properties of tissue that a traditional camera cannot detect. In this chapter the 
operational principle, calibration, and testing of a spectral imaging device is described. In 
chapter 8 we discuss how this device is modified for widefield clinical imaging. The 
technique, called Image Mapping Spectrometry (IMS), is a spectral imaging technology 
that simultaneously captures spatial and spectral information about an object in real-time. 
Here we present the calibration procedure for the IMS as well as the first detailed 
 72  
 
evaluation of system performance. We correlate optical components and device 
calibration to performance metrics such as: light throughput, scattered light, distortion, 
spectral image coregistration, and spatial/spectral resolution. Spectral sensitivity and 
motion artifacts are also evaluated with a dynamic biological experiment. Results are 
important to any potential users/developers of an IMS instrument and to anyone who may 
wish to compare the IMS to other imaging spectrometers.  
7.1.  Introduction  
Hyperspectral imaging (HSI) is utilized throughout the fields of astronomy [79], 
remote sensing [80], food science [81], and biotechnology [82].  By collecting both 
spatial and spectral information about an object, it provides a full three-dimensional 
distribution, called a hyperspectral datacube. Linear unmixing or other spectral analysis 
algorithms can use this spatial-spectral dataset in order to identify concentrations of 
chemicals within a scene. [83]. Traditional hyperspectral imagers implement a temporal 
scanning technique to sequentially collect the hyperspectral datacube by either point-
scanning, line-scanning, or wavelength-scanning [84]. These systems include pushbroom, 
whiskbroom, liquid-crystal tunable filter (LCTF), and acousto-optic tunable filter 
(AOTF) imaging spectrometers. More recently, a class of hyperspectral imagers has 
come forward that collects the entire datacube simultaneously. Some examples of such 
systems are the Computed Tomographic Imaging Spectrometer (CTIS) and the Coded 
Aperture Snapshot Spectral Imager (CASSI) [85-87]. These “snapshot” instruments 
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incorporate specialized components to distribute an object’s three-dimensional spatial-
spectral information onto a two-dimensional focal plane array. A transformation is then 
used to reconstruct the three-dimensional hyperspectral datacube from the two-
dimensional image recorded on an image sensor.  
Another class of hyperspectral imaging systems provides all spatial-spectral 
information on a single or multiple CCD image sensors with a one-to-one correspondence 
between datacube voxels and detector pixels. There are three major modalities in this 
group: Image Slicers [88], field splitting by fibers [89] or lenslet arrays [90], and Image 
Mapping Spectrometers (IMS) [91-93]. By collecting information simultaneously, while 
utilizing simple datacube remapping algorithms, these systems add several powerful 
capabilities to hyperspectral imaging, including: faster data collection and image 
reconstruction, higher light-throughput, less motion artifacts, and real-time spectral 
unmixing. These features enable applications that require the ability to distinguish objects 
with similar spectral properties at high temporal resolution. Of particular interest is an 
IMS system that demonstrates high spatial sampling of 355 x 350 over 41 wavelengths, 
using a single large format CCD image sensor. It also provides high light throughput of 
above 50%. In the field of bioscience, the IMS has been used to investigate cellular 
dynamics with multiple fluorescent biomarkers [94], to perform real-time brain imaging 
[95], and for endoscopic imaging of oral mucosa [72].  
While previous publications presented datacubes and experimental results that 
show IMS' basic performance [72, 91-95], a detailed discussion of system calibration and 
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characterization of its operational limits has not yet been published. In Section 2, this 
chapter sites the current literature related to IMS calibration and hardware performance. 
In Section 3 an improved spatial-spectral calibration procedure is presented for the IMS. 
This new method is necessary to account for imperfections in raw detector data. Section 4 
describes a suite of tests developed to measure optical performance of the IMS after 
calibration. The measured performance metrics are linked to imperfections in optical 
components/assembly as well as system calibration. The tests can readily be applied to 
other microscope-coupled hyperspectral devices (Image Slicers, pinhole systems, etc.). In 
Section 5, motion artifacts and spectral linear unmixing of the IMS are tested with a real-
time biological experiment. The results of the performance tests provide the first 
benchmark for IMS technology. Potential users/designers of IMS instruments can draw 
also from the tests and analyses in order to design experimental setups, evaluate their 
systems, or compare to other imaging spectrometers. 
7.2. Background 
The detailed principle of the IMS system operation was first described in [92]. It 
is useful to briefly describe how the IMS operates in order to discuss calibration 
requirements and relate performance results to hardware components. Here we limit the 
discussion to focus on the principle/component impact on imaging performance.  




The IMS breaks an image into zones to create void regions. This is accomplished 
through a specially designed mirror and an array of re-imaging systems. The image zones 
are then dispersed and spatial-spectral information from the object is recorded on a CCD 
image sensor. The essential component is the "image mapping mirror" also called an 
image mapper. The component is placed in the image plane of fore optics and in its 
simplest form is a faceted mirror composed of many reflective long strips. The facets of 
Figure 7-1: The operating principle of the IMS system. 
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the mirror have different two-dimensional tilt angles that reflect image zones into 
different directions. Figure 7-1 shows a schematic of the IMS system that contains a 
simplified mirror with only twelve facets. The image mapping mirror used in the 
evaluated system has 355 facets. 
 
 
For the purposes of this publication the authors will not analyze optical design 
and tolerance analysis since this topic was already discussed in [72, 91]. We will focus 
here on evaluation of performance of the system “as is,” which may help potential 
Figure 7-2: (A) The image mapping mirror is composed of 350 reflective facets that are 
65 µm x 25 mm long, each with a two-dimensional tilt angle to redirect image zones. (B) 
A close-up image of eight mirror facets with roughness and debris indicated. (C) White 
light interferometry data shows roughness on facets as well as edge artifacts. 
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users/builders characterize their systems. The image mapping mirror design, fabrication, 
and optical characterization was discussed in [93]. The authors showed that the 
fabrication process results in imperfections within mirror facets, such as surface form 
error, roughness, and width variations (as shown in Figure 7-2). Since the facets lie at an 
intermediate image plane, these imperfections produce artifacts in the collected data. In 
this chapter we discuss how these imperfections affect reconstructed datacubes. 
The sliced and dispersed raw IMS image is not “human readable” and must be 
remapped in order to reconstruct a spatial-spectral datacube. A basic, proof-of-concept 
mapping calibration procedure was presented in [91]. This approach did not account for: 
monochromatic and polychromatic distortions, defocus, or clipping within the optical 
train of the system. The reconstruction of datacubes using this previous calibration 
method produced datacubes with lateral chromatic aberration and spatial misalignments.  
7.3. Calibration 
The calibration procedure discussed here has not been published, but it has been 
used to calibrate the systems described in our previous publications [64, 72, 94, 95]. In 
order to clarify the calibration procedure, we will first briefly describe the raw data from 
the IMS evaluated in this chapter. Our experimental system contains an image mapping 
mirror with 355 mirror facets that redirect image zones into twenty-four different sub-
images on the detector (corresponding to four vertical and six horizontal facet tilt angles).  
Redirected lines from the object are separated by 41 pixels, which allows for 41 pixel 
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spectral sampling. Figure 7-3 shows false-colored raw data from the IMS. The data in 
Figure 7-3a/b is recorded from an empty microscope stage lit with Koehler illumination 
from a halogen lamp. A neutral density filter and a daylight filter were used to match the 
spectral density of the lamp to the sensitivity of the CCD, which created a uniform 
detector signal over the broad spectrum. The spectral range was limited to 470 - 670 nm 
using a bandpass filter in order to prevent overlap of dispersed light between adjacent 
facets. Figure 7-3c shows a subsection of the IMS's CCD imaging a pinhole illuminated 
with 470 – 670 nm light; here one pixel of spatial information and 41 pixels of dispersed 
spectral information are recorded. Figure 7-3d is the raw data from a pinhole illuminated 
with narrowband 550/1 nm light.  
 
Figure 7-3: The IMS detector response to different spatial and spectral samples. (A) 
Detector response to uniform sample illuminated with white light (false-colored to 
illustrate spectral content). (B) Close-up of one dispersed facet image, which 
corresponds to the spatial-spectral information of one line in the object. (C) Response 
to spatial point-source (i.e. a pinhole) illuminated with white light. (D) Response to a 
spatial point-source illuminated with narrowband (550/1 nm) light. 
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We primarily use the IMS to image thin microscope samples with negligible 
depth information, therefore our calibration establishes a one-to-one correspondence 
between each voxel in the hyperspectral datacube (x, y, λ) and a pixel location on the 
CCD camera (u, v) [91]. The complete calibration procedure consists of three steps: (1) 
Remapping with the transformation lookup table (x, y, λ) = T-1{(u, v)}, (2) Flat-field 
correction, and (3) Spectral sensitivity correction.  
The goal of the mapping calibration step is to determine (x, y, λ) = T-1{(u, v)}. T-1 
is effectively a lookup table that is the same size as the datacube, which contains a 
subpixel detector value at each index. In order to determine T-1, the forward mapping T is 
found first by sequentially illuminating integer coordinates (x, y, λ) throughout the 
datacube while analyzing the detector (u, v) response. Once we establish the relationship 
T from scene to detector, we can apply the reverse mapping T-1 or “remapping” to 
transform raw detector data into a datacube. The procedure works by scanning a spatial 
pattern (e. g. a pinhole) illuminated with four narrowband filters throughout the field of 
view (FOV) of the IMS system at (x, y, λ) object coordinates. Each position of the spatial 
pattern provides a point image in a region on the detector (Figure 7-3d/4a). The subpixel 
center position (u, v) of the point image is determined with a peak-finding algorithm [59]. 
Forward mapping and reverse mapping are conceptually illustrated in Figure 7-4. 
Parameters used during the calibration procedure are shown in Table 7-1. Remapping the 
datacube c using the lookup table is implemented in real-time using bicubic interpolation 
[96] of raw detector data. Section 4D evaluates the accuracy of remapping. 
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ܿ = 	݅݊ݐ݁ݎ݌2(ݎܽݓ, ݈݋݋݇ݑ݌)     (1) 
Flat-field correction is also performed in order to account for intensity variations 
in the raw image. The procedure starts by recording a datacube i from an empty 
microscope stage lit with halogen lamp Koehler illumination. All subsequent datacubes c 
acquired by the IMS are divided by the datacube acquired with Koehler illumination. 
Figure 7-4: Sequential experimental calibration procedure. (A) Each element of object 
space (x, y, λ) can be illuminated sequentially with a spatial-spectral point source while 
recording the detector (u, v) response. The forward mapping of object coordinates to 
detector space describes T{(x, y, λ)} → (u, v). (B) Applying the remapping T-1{(u, v)} → 
(x, y, λ) allows the object datacube to be accurately reconstructed from raw data. (C) 
Subpixel coordinates obtained from the mapping calibration are overlaid on raw detector 
data. 
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This normalizes the response of every datacube voxel. Next, the spectral sensitivity is 
corrected. Each of the N spectral images λ within the datacube is multiplied with a 
correction factor s to match the corresponding intensity of the halogen lamp spectrum, as 
determined by a calibrated point spectrometer. The final datacube final includes both flat-
field and spectral correction of the raw detector data [97]. 
݂݈݅݊ܽఒୀଵ:ே 	= (ܿ./݅)ఒୀଵ:ே .∗ ݏఒୀଵ:ே    (2) 
 
 
7.4. IMS Evaluation Tests 
There are no established standards for performance evaluation of snapshot 
hyperspectral imagers. For that reason, in order to assess the hyperspectral datacubes 
obtained from the calibrated IMS, we developed a suite of tests to measure different 
metrics of data quality. We decided to evaluate three categories of IMS data quality: 
intensity parameters, mapping errors, and overall performance. Intensity parameters are 
Table 7-1: Calibration parameters and settings for the evaluated IMS system. 
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inherent to the hardware of the system and are evaluated with tests for intensity variation, 
light throughput, and scattered light. Mapping errors are dependent on the accuracy of the 
calibration lookup table and are evaluated with tests for geometric error, image stretch, 
and spectral image coregistration. Overall optical performance tests include spatial 
resolution, spectral resolution, and spectral accuracy/variability. While some of the tests 
are specific to the IMS instrument, many of the procedures can also be used to measure 
performance of other hyperspectral imaging techniques. The IMS specific tests are 
indicated with asterisks in Table 7-2. Each section below summarizes the algorithm used 
for the test and the results found for the calibrated IMS.  
 
Table 7-2: Measured Parameters of the IMS Camera. Tests without an asterisk (*) can 
also be used to evaluate other hyperspectral imagers. 
 
 
During testing the IMS system was coupled to the side port of a Zeiss Axio 
Observer inverted microscope. Two spatial targets were used: a Ronchi ruling rotated at 
0o, 45o, and 90o, and a high-resolution 1951 USAF resolution target. Several narrowband 
and plastic transmission filters were used to evaluate spectral performance. All remapped 
datacubes were obtained according to the calibration procedures described previously. 
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A. Intensity Variation  
Ideally, the intensity of reflected light collected from the image mapping mirror 
should be constant. In reality, the uniformity of the detector image is affected by: the 
image mapper quality [93], the re-imaging optical train, and the CCD response. It is 
important to measure variations in the raw detector image because they correspond to 
loss in dynamic range. For example, if one facet image or a portion of a facet image is 
less intense than another, then this area will have lower signal-to-noise ratio and dynamic 
range. During calibration, flat-field correction was used to aesthetically compensate 
nonuniformities in the datacube [97].  
To assess the amount of total system non-uniformity, Koehler illumination was 
used in transmission mode with a halogen lamp to uniformly irradiate an empty 
microscope stage. Figure 7-5a shows raw data from the IMS obtained with this setup. 
Facet images do not have a constant intensity value within or between facets. Figure 7-5b shows the optical components that most likely contribute to these intensity 
variations in the data. For example, imperfection in mapper fabrication causes debris and 
roughness on facets, which create localized decreases in image intensity. Light that is 
clipped by the collecting objective creates regions of missing information in the corner 
sub-images. Also, prism/lens array alignment can cause defocus of facet images, which 
reduces intensity. These artifacts affect other important metrics of datacube quality in 
addition to intensity variation. For example, defocus of a facet image will cause blur in 
 84  
 
the direction of spectral dispersion, which reduces spectral resolution, as discussed in 
Section 4F. Figure 7-5c reveals a close-up reconstruction of nine uniformly-illuminated 
facet images in the image mapping mirror. Contrast has been enhanced to highlight the 
overall change in intensity that can be seen on each reconstructed line.  
 
A Matlab script was written to quantify variation of facet image intensities on the 
detector, which is an overall measure of image mapper variations, vignetting, clipping, 
Figure 7-5: (A) Left: A flat-field broadband image from the IMS with varying facet 
image intensity. Right: A close-up of a flat-field narrowband facet image from the IMS, 
showing defocus of the facet. These design, fabrication and assembly limitations cause 
intensity variations in the raw data. The superscript number corresponds to the system 
component in (B) which causes the problem.  (C) A contrast-stretched image of nine 
facets after remapping shows overall and localized facet image non-uniformities. These 
flaws also translate to reduced resolution, missing data and/or geometric errors in the 
remapped datacube.  
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prism/lens array affects, as well as reconstruction. To quantify the uniformity of intensity 
within facet images, the relative standard deviation (%RSD) was calculated for each facet 
image in the panchromatic flat-field datacube. The %RSD of intensity within facets 
ranged from 2.6 to 26%, which indicated that some facets have significant internal non-
uniformities. On average, there was an 11% RSD of intensity within a facet.  Comparing 
the mean intensities between all facets, there was an 8.6% RSD between facets (the value 
was calculated as an average irradiance for each facet). This suggests that localized 
variations in facet reflectivity have a more significant effect on image non-uniformity 
than overall facet-to-facet variation.  
B. Light Throughput  
The next test for the IMS system was to measure optical efficiency of our system, 
defined as the ratio of light entering the system to light recorded on the detector. To 
examine throughput of the IMS, an iris was placed at the sample plane of a microscope 
and illuminated with narrowband light at three wavelengths. By moving the IMS's CCD 
detector, light levels were captured at three locations in the system: at the side port of the 
microscope, at the mapping mirror, and at the IMS detector plane. The light intensity and 
integration time were kept constant throughout the experiment, such that the CCD was 
below saturation at each location; also, the extent of the field was limited so that the 
entire sample was captured on the CCD. Light intensity at each location was determined 
by summing all pixels on the CCD after a background subtraction.  
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Figure 7-6a illustrates the experimental setup and example imaging results from 
one wavelength test. Complete results are graphed in Figure 7-6b. We measured the relay 
arm to have 89% throughput, which includes an objective, tube lens, and spectral filters. 
The redirecting and dispersing optics of the system are ~65% light efficient, which 
corresponds to a total light efficiency of 58%.  
C. Scattered Light  
Scattered light is defined as any light that reaches the detector other than defined 
by the optical system design. In general, scattered light originates from diffuse reflection 
and back-reflection off optical surfaces. As light passes through a surface a small amount 
of scatter occurs that can appear as background in the image, thus reducing contrast and 
signal-to-noise ratio. Devices with a large number of elements such as the IMS can be 
more prone to effects related to scattered light. In the IMS, light from the sample passes 
more than twenty surfaces, including the image mapper, prism array, and lens array. To 
Figure 7-6: Light throughput test. (Left) The three locations that light was measured 
using a large-format CCD. (Right) A graph of the overall intensity at each location, 
plotted for three different wavelengths. 
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assess whether this significantly affects image quality, scattered light was measured in an 
IMS datacube as well as in a digital image from a standard scientific grade CCD camera 
(Qimaging Retiga EXi) placed at the microscope side port.  
 
 
In order to measure scattered light, an approximation was made about the Ronchi 
ruling images: the center of the dark regions should be exactly zero (although, in reality 
the contrast is not exactly 100% at this spatial frequency - therefore this is a conservative 
approach for the measurement). Any loss of contrast within dark regions of the Ronchi 
images were assumed to be from scattered light. For the IMS data, each of the Ronchi 
ruling datacubes (0o, 45o, 90o) were first flat-field corrected according to the calibration 
procedure and then background-subtracted to reduce the effect of dark current. Each 
spectral image was segmented into three groups: a “high” group that contained pixels 
with normalized intensity greater than 0.75, a “low” group normalized intensity less than 
Figure 7-7: (A) An image of a Ronchi ruling acquired with a standard CCD camera 
placed at the side port of a microscope. After background subtraction and flat-fielding, 
the signal to background ratio was measured to estimate scatter. (B) A similar procedure 
was repeated for each spectral image of three IMS datacubes; the results are graphed on 
the right.   
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0.25, and other. Next, the sum of low intensity regions was calculated and divided by the 
high intensity regions. The resulting “mean scatter” value was found for each spectral 
image independently to produce a vector of scatter vs. wavelength (see Figure 7-7). The 
average scattered light over all wavelengths and all Ronchi ruling orientations was 
9.79%. The same procedure was repeated for flat-field, background, and Ronchi ruling 
images acquired with the standard CCD camera placed at the side port of the microscope. 
In this case, we measured the mean scatter to be 6.81%. This suggests the microscope 
system and/or the Ronchi ruling is responsible for the majority of scatter. Therefore, the 
IMS recorded spectral images with approximately 3% more scattered light than measured 
by the standard CCD.  
D. Geometric Error and Stretch  
The geometric error distortion causes straight lines in object space to appear 
curved in the image. Although curvature of facet images is apparent in the raw IMS data 
(see Figure 7-3), the mapping calibration procedure should correct this aberration in the 
datacube remapping. However, several factors could leave geometric errors in the 
datacube, such as noise in the calibration data and damaged/missing facet images. In the 
Ronchi ruling datacubes, these factors could result in distortion-like geometric errors that 
cause the bar features to appear curved.  
To test the amount of distortion-like geometric error, the corrected 45o datacube 
was analyzed. First, a Sobel edge filter was used to identify the edges of bar features in 
the panchromatic image. For each edge a line was fit and then the coefficient of 
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determination R2was calculated (see Figure 7-8 left). The average R2 value for the eleven 
detected edges was 0.999, which indicated that there is minimal distortion in 
reconstructed IMS images.  
 
We also checked for any difference in magnification between the x- and y-
directions of the datacube. Such an anamorphic magnification can stem from errors in the 
mapping calibration. To check for this error, estimates for the widths of the Ronchi ruling 
bars in the two orthogonal directions were calculated. First, the datacubes were aligned to 
the vertical axis. A stretch factor was defined as the normalized ratio between the two 
measured widths w, 
ݏݐݎ݁ݐܿℎ = 	 ௪఼	ି௪‖
୫ୟ୶	{௪఼	,௪‖}      (3)  
Figure 7-8: (Left) The geometric error test was used to look for distortion-like curvature 
in the image as well as jagged edges. The blue lines represent the edge of the bar feature 
and the red is the first-order fitted line. (Right) The width of bar features were 
calculated for panchromatic images of the horizontal and vertical Ronchi ruling.  
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The widths were measured in integer pixel units. In the case of the data shown 
here, the width estimation for both the 0o and 90o rulings were 40 pixels, therefore the 
measured stretch was 0%.  
E. Coregistration Test 
To further assess the accuracy of datacube reconstruction, another test was 
developed to measure the spatial coregistration of spectral images. Problems with spatial 
coregistration of spectral images could be a result of inaccurate mapping calibration or 
strong chromatic aberration in the system. Taking the flat-fielded Ronchi ruling 
datacubes, each spectral image was converted to a binary image using a threshold. The 
overlap between every thresholded spectral image with every other thresholded spectral 
image was then calculated by summing pixels at each spatial position. A perfect 
registration was achieved by registering a given spectral image with itself, and this was 
used as a normalization of the result to give a “percentage" coregistration. Since this was 
calculated between every pair of spectral images, the result was a matrix.  
Figure 7-9 shows the three coregistration matrices obtained from the test and their 
mean coregistration values. The three matrices correspond to the 0o, 45o, and 90o Ronchi 
images. Diagonal elements were set to zero and the log of the percentage registration was 
taken in order to improve visibility of off-diagonal elements. A perfect coregistration of 
spectral images within a datacube would result in a matrix of zeros. The linear features 
(dark/bright horizontal and vertical lines seen Figure 7-9a) in the matrices of measured 
datacubes indicated that the coregistration was lower or higher for some wavelengths 
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relative to others; or in some cases they revealed individual spectral images that had 
prominent mapping errors over a few spatial lines. The quantitative result of this test was 
the mean of all off-diagonal elements, which showed greater than 99% spatial 
coregistration of all spectral images.  
 
F. Spectral Resolution  
Spectral resolution is the minimum difference between two wavelengths that a 
device can distinguish. The spectral resolution of the IMS is influenced by the dispersive 
properties of prisms/lens array in the system and the pixel sampling. It can be roughly 
estimated by dividing the spectral range by the number of resolvable bands in the IMS. 
Our system is designed to sample 200 nm over 25 spectral bands, which results in an 
Figure 7-9: Coregistration evaluation results (log scale) indicate the coregistration of 
spectral images within perpendicular (A), diagonal (B), and parallel (C) Ronchi ruling 
datacubes. The diagonal elements have been zeroed out to improve visibility of off-
diagonal elements. Average coregistration for these datacubes are 99.62, 99.58, and 
99.58%, respectively.  
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average spectral resolution of 8 nm [91]. The spectral resolution of the IMS, however, 
varies nonlinearly with wavelength due to nonlinear dispersion of the prisms. It also 
depends on accurate calibration mapping. Therefore it is important to measure this 
parameter for several wavelengths throughout the spectral range. 
A method for estimating spectral resolution is to measure an object with spectral 
features smaller than the resolution limit of the system (i. e. a monochromatic source or a 
lamp with sharp spectral peaks). The convolution of the object with the system response 
will yield a result which approximates the smallest resolvable feature, measured as the 
full-width half-maximum (FWHM) of the point spread function (PSF) [98]. To measure 
spectral resolution in the IMS, several 1-nm FWHM spectral filters were used to 
illuminate an empty microscope stage. Spectral resolution was tested at five wavelengths: 
488.0, 514.5, 532.0, 589.6, and 632.8 nm.   
Figure 7-10a shows a matrix of the measured spectral resolution for the 488.0 nm 
filter over the field of view, which reveals how resolution varies throughout the field. 
Periodic variation was most likely influenced by defocus of facet images; for detail 
please see in Figure 7-5a. The hardware error that contributes most to this effect is 
misalignment/tilt of prisms or lenslets within the array. Figure 7-10b shows the 
representative spectral response to each filter. The green line represents data from the 
IMS and the blue line is a spline fit to the IMS data, which was used to estimate the 
FWHM of the PSF. Figure 7-10c reports the measured and theoretical spectral resolution 
for each wavelength.  
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G. Spectral Accuracy and Variability  
Spectral accuracy and variability were first assessed with the five narrowband 
filters used for spectral resolution tests. The peak location of the fitted spline curve was 
calculated for each point in the image. Figure 7-10d reports the measured center 
wavelength of each filter and the standard deviation for these values throughout all IMS 
spectra. The mean value of IMS spectra falls within 0.1 to 1.7 nm of the nominal peak 
wavelength for each filter. 
Figure 7-10: (A) The spectral resolution throughout the image shown at 488 nm; 
grayscale intensity (r) indicates the FWHM of the IMS spectral response. (B) The 
spectral response at spatial point (150, 150) to each spectral filter; green indicates raw 
data and blue is the fitted spline. (C) Statistics for spectral resolution at all spatial points 
in the image. (D) Statistics for spectral accuracy and variability in the image. 
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The accuracy and precision of IMS spectra were also measured using five standard 
plastic transmission filters (Roscolux) and an Ocean Optics Spectrometer (OOS USB-
4000). Each filter was placed in the illumination path of the microscope and the 
transmission spectrum was measured with the IMS and OOS. Each spectrum was divided 
by the spectrum of the halogen lamp to yield percent transmission. Figure 7-11 shows the 
results of three spectral measurements. There was low variability throughout the IMS 
spectra, with standard deviation 0.5 – 4.5%. IMS spectra closely matched the OOS in the 
shorter wavelength, but had up to 15% error in the red. The discrepancy is a result of 
decreased spectral resolution found in the longer wavelengths. Similar behavior is 
described in other hyperspectral imaging systems and there is clearly known 
methodology for correcting this type of error [99, 100]. The exact correction includes 
extensive deconvolution procedures, which are out of the scope of this chapter.  The level 
of error is acceptable for the relative spectral measurements required in our current 
applications [94, 95].  
 
Figure 7-11: Transmission spectra of Roscolux© plastic filters acquired with the IMS and 
an Ocean Optics Spectrometer. The green line indicates the Ocean Optics Spectrometer 
results. The red line indicates the mean of IMS spectra at all spatial points with dashes 
indicating standard deviation.  
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H. Spatial Resolution, Field of View, and Sampling 
The IMS differs from most imaging systems because the image mapping mirror, 
which exists in an intermediate image plane, redirects image strips to separate locations 
on the detector. The system therefore inherently samples the x- and y-direction 
differently. In the x-direction, the image is sampled by the discrete number of facets in 
the image mapper. These facets are projected onto separate locations on the pixel 
detector, where they are sampled in the y-direction by connected pixels. The remapping 
calibration then determines subpixel intensity values based on these whole pixels using 
bicubic interpolation. The first goal of this test was to measure the effective spatial 
sampling of the IMS.  
By design, there are 355 (facets) x ~350 samples over the image plane of the IMS 
datacube. Aberrations introduced by reimaging the image mapping mirror onto the 
detector can reduce the effective y-sampling to below 350 pixels. Also, an accurate 
mapping calibration is necessary to sample facet images at the correct locations and 
sampling rate. By analyzing lookup table data, it was found that facets were sampled by a 
mean of 340.81 +/- 1.21 vertical pixels, which corresponds to 0.97 reconstruction 
samples/pixel. Therefore, the effective spatial sampling of the IMS is 355 x ~341 integer 
pixel samples, while the image size is slightly oversampled to 355 x 350 after the 
mapping calibration.  
Given a fixed number of spatial samples, the spatial resolution and FOV of the 
IMS are primarily dependent on the relay lenses chosen to image the object onto the 
 96  
 
image mapper. Depending on the desired application, the spatial samples could be used 
either to maintain a high spatial resolution with small FOV or to acquire a large FOV 
with low spatial resolution. Diffraction limited performance of the IMS was already 
discussed in [92, 93]. Here we present results for qualitative assessment of imaging 
performance and contrast using a high-resolution 1951 USAF target. The object plane of 
the IMS was positioned at the Zeiss microscope side port image, which has an NA of 
0.01875. A 5X relay objective was used to match two IMS facets to each side port image 
airy disk diameter. Figure 7-12 shows a panchromatic image of the target acquired with 
the 5X relay objective and a 40X/0.75NA microscope objective. The Group 9 Element 3 
bars are 0.78 µm wide and clearly resolved.  
 
 
7.5. Motion Artifacts and Spectral Linear Unmixing  
The tests shown thus far in this chapter were used to evaluate the performance 
limits of the IMS. With an understanding of these limits, experiments can be designed for 
applications that require a fast and dense spatial/spectral dataset. The IMS system has two 
powerful capabilities that make it useful for demanding spectral imaging applications: (1) 
Figure 7-12: The IMS coupled to a 
microscope was used to image a high-
resolution 1951 USAF target. 
Panchromatic images are shown. 
Group 9 Element 3 is 0.78 µm wide. 
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the ability to distinguish objects with similar spectral features, and (2) the ability to 
record dynamic processes. Here we provide a final qualitative test that evaluates these 
capabilities.  
The IMS was used to measure oxygen saturation in vivo during an arterial finger 
occlusion experiment, following a Rice University IRB-approved normal volunteer 
protocol. This application particularly benefits from the snapshot capability of IMS 
because: (1) fast, non-scanning data collection is less susceptible to motion artifacts; and 
(2) dynamic changes in tissue oxygenation can be recorded and displayed in real-time. 
With the IMS coupled to a commercial camera lens, images were collected images at 7.2 
frames per second and 100 ms exposure of a hand illuminated with a white LED 
(Thorlabs MCWHL2). At the beginning of the experiment one of the fingers underwent 
total arterial occlusion using a rubber tourniquet. After one minute the tourniquet was 
removed and arterial circulation continued. Figure 7-13 presents spectral imaging results 
from five different time points. The true color images show the occluded finger becoming 
slightly pale, then reddish and swollen after blood circulation continued. The “ROI 
Spectra” shows absorption spectra at each time point, which contain characteristic 
hemoglobin peaks between 500 – 600 nm. Spectra obtained from a region before and 
after the occlusion were considered deoxy-hemoglobin (Hb) and oxy-hemoglobin (HbO2) 
reference spectra, respectively. These spectra contain only slight differences and cannot 
be quantitatively distinguished with a standard color camera. The IMS, however, can 
easily differentiate the spectra.  
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Using hemoglobin reference spectra, spectrally unmixed images were created to 
show the relative distribution of Hb and HbO2 in the hand. Reference [83] describes in 
general how this linear unmixing is performed. The “Unmixed” images depict maps of 
the relative reference spectra throughout the experiment. Finally, the Hb and HbO2 
Figure 7-13: To demonstrate the spectral unmixing capability of the IMS for a dynamic 
application, an arterial finger occlusion experiment was performed.  The true color 
images show the occluded finger becomes pale after 40s without blood flow and then 
swells with oxygenated blood after the occlusion is removed. Using reference spectra 
from before and after the occlusion, spectrally unmixed images were created to show 
distribution of deoxy-hemoglobin (blue) and oxy-hemoglobin (red). Finally, the ratio 
HbO2/(Hb+HbO2) was calculated for each pixel to reveal relative oxygen saturation in the 
sample.  
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unmixed images were used to visualize relative oxygen saturation in the tissue, defined 
as:  
ܱଶ	ܵܽݐݑݎܽݐ݅݋݊ = 	 [ு௕ைమ][ு௕ைమ]ା[ு௕]    (4) 
 
These images significantly increase contrast between oxygenated and 
deoxygenated tissue. Such dynamic measurements can be used to determine vascular 
function during ischemia and reactive hyperemia [101]. 
Throughout the experiment, movement of the hand had no significant impact on 
imaging performance. The snapshot nature of the IMS system resulted in images with 
traditional motion blur seen in standard CCD images, while maintaining coregistered 
spectral images and accurate spectra, as can be seen in the supplemental movie. 
Qualitative analyses of results also indicate spectral linear unmixing accurately 
determined the weighting of reference spectra throughout the experiment. Therefore, this 
test suggests that the calibrated IMS system is capable of measuring distributions of 
reference spectra during a dynamic experiment.  
7.6. Discussion 
This chapter presents the first spatial-spectral calibration and characterization of 
an Image Mapping Spectrometer. Radiometric tests indicate that the IMS has high optical 
throughput (~58%) and negligible scattered light. Geometric calibration results show 
minimal distortion/stretch and high coregistration, which indicates the raw two-
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dimensional detector data is accurately remapped to a datacube. Spectral characterization 
reveals ~6 nm spectral resolution in the blue wavelength region up to ~16 nm in the red. 
Although broadband spectral tests show up to 15% error in the red wavelength-region, 
testing with narrowband light indicates spectral bins are accurate to < 2 nm. A high-
resolution 1951 USAF target was used to show image quality of the IMS. Finally, an 
arterial occlusion experiment demonstrated qualitative dynamic imaging performance and 
spectral unmixing capability. With this new information, a set of specifications now 
exists to compare this IMS to future IMS devices. These specifications, as well as the 
description of the tests used to obtain them, is particularly beneficial for end-users to 
evaluate their systems and design appropriate experiments. Moreover, this work allows 
for comparison to different hyperspectral imaging modalities.  
Although the evaluation tests here address several aspects of datacube quality, the 
list is not exhaustive. Future work will implement deconvolution techniques to improve 
spectral calibration. Finally, the optical design, assembly, and fabrication can be 
improved as more advanced manufacturing procedures become feasible. As hyperspectral 
imaging hardware, calibration, and data analysis technologies progress, exciting new 
applications will become possible. 
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Chapter 8 
Multi-modal snapshot spectral imaging 





Oral cancer is a significant global health problem, ranking as the sixth most 
common cancer worldwide. Optical imaging and spectroscopy have emerged as effective 
tools for detecting malignant changes associated with oral cancer disease progression. 
While clinical studies have demonstrated high sensitivity and specificity for early disease 
detection, current devices either interrogate a small tissue region or have reduced 
performance for challenging benign conditions such as inflammation, lichen planus, and 
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hyperkeratosis. To address these clinical challenges, we developed a new optical 
modality that combines the large field-of-view of widefield imaging with the diagnostic 
strength of spectroscopy. The portable device is capable of streaming true-color images at 
7.2 frames per second and recording both autofluorescence and reflectance spectral 
datacubes in < 1 second. We describe initial data from the device obtained from normal 
volunteers and an oral cancer clinical trial.  
8.1. Introduction  
Oral cancer is a significant global health problem. In the US alone, around 40,000 
people will be diagnosed with oral cancer this year and 8,000 will die from the disease. 
That amount equals approximately one death for every hour of every day. More than half 
of the individuals diagnosed with oral cancer will die within five years, because it is 
typically discovered in a later stage when treatment is less effective. Unfortunately, these 
numbers have not improved for decades.  
Although the need for early diagnosis is clear, there are many factors that 
contribute to delay. The standard screening practice for oral cancer is visual inspection 
and palpation. During this procedure, clinicians check for abnormal lesions such as 
leukoplakia and erythroplakia, which appear as white and red patches in the oral cavity 
[105]. These lesions can be confused with benign conditions such as lichen planus, 
inflammation, and hyperkeratosis. Therefore, localized oral cancer may appear benign to 
a physician and could remain unsuspicious until an advanced stage. Lesions that are 
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suspicious should be biopsied to determine disease status, but the invasiveness of the 
procedure could lead to hesitation that prolongs diagnosis. Biopsies also take time to 
process and examine, adding to patient stress and prolonging the time to diagnosis. In 
addition, the small tissue region being sampled by a biopsy may not represent the highest 
pathological grade of a heterogeneous tumor [106].  
Screening with optical imaging and spectroscopy has the potential to address 
these clinical challenges. Morphological and biochemical changes occur during cancer 
progression and these alterations can be detected with non-invasive optical devices. For 
example, epithelial cancers cause breakdown of stromal collagen as well as changes in 
NADH/FAD [107]. These alterations can be identified within autofluorescence spectra of 
the tissue. Cancer also disturbs the vasculature and metabolic activity within the tissue 
microenvironment, which can affect autofluorescence and reflectance spectra. Several 
clinical studies have used point spectrometers to detect these changes in autofluorescence 
and reflectance. These studies found that spectral shape, intensity, and peak can be used 
to classify oral cavity lesions with 94% sensitivity and 90% specificity [108, 109]. 
Although point devices can provide an accurate diagnosis, their small sampling area 
makes it is difficult to screen the entire oral cavity for disease.  
Another modality called widefield autofluorescence imaging can screen several 
centimeters of tissue at one time. When excited with blue light, normal tissue emits a pale 
green color that can be detected visually or with an image detector array. Dysplastic and 
cancerous regions that have reduced autofluorescence appear darker [110]. A widefield 
autofluorescence device called the Velscope is now FDA approved as an aid for oral 
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cancer detection [105, 111-113]. While the effectiveness of widefield autofluorescence 
imaging shows great potential for early detection of oral cancers, acquiring additional 
spectral information may increase specificity when imaging difficult or benign lesions.  
An ideal approach for early cancer diagnostics could be to combine widefield 
imaging with spectral acquisition. This can be accomplished with spectral imaging, 
which is a new optical modality that collects a full set of spatial and spectral information. 
A full spatial-spectral “datacube” could enable screening of a large field of view with the 
added diagnostic strength of spectral information. For example, in reflectance mode, oxy- 
and deoxy-hemoglobin peaks can be visualized, which enables imaging of vascular 
activity and oxygen saturation in vivo over the entire tissue region [101]. These peaks 
cannot be distinguished using a conventional three-color CCD. Similarly, 
autofluorescence changes associated with cancer progression can be better visualized 
with a full spectrum [109].  
Spectral imaging for cancer diagnostics is a relatively new field. Most current 
imaging spectrometers require a scanning mechanism to sequentially collect spatial and 
spectral data, which can be time consuming and impractical for some applications. For 
instance, clinical imaging spectrometers have been built that utilize liquid-crystal tunable 
filters to collect one spectral image at a time on a CCD sensor [114]. With long exposure 
times for each spectral image, this acquisition process results in motion blur that reduces 
accuracy of spatial/spectral features in the datacube.  
In this chapter we present a new type of clinical imaging spectrometer that 
captures all spatial and spectral data simultaneously with high light throughput. The 
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device can collect data in either autofluorescence or reflectance modes in order to acquire 
different morphological and biochemical alterations associated with cancer progression. 
Multimodal datacubes with 350 x 350 spatial x 42 spectral samples are acquired in 
reflectance and autofluorescence mode with an acquisition time of < 1 second. We assess 
the diagnostic value of the multimodal device with a pilot study of eleven oral cancer 
patients. Spectral images and spectra are shown for several normal and abnormal regions 
and preliminary analysis is presented. 
8.2. Methods 
Instrumentation 
We built a custom multimodal snapshot imaging spectrometer based on a research 
instrument called the Image Mapping Spectrometer (IMS). The IMS has been used for 
live cell microscopy [94], animal imaging [95], ophthalmology [115], and endoscopy 
[72], but never for a multi-patient clinical study. An ideal clinical research device is 
compact, portable, rugged, non-invasive, and user-friendly. To modify the IMS for these 
clinical requirements, we mounted the device to a portable tripod, attached a consumer-
grade camera lens for wide-field imaging, and developed a software-controlled 
illumination and acquisition system, as shown in Figure 8-1.  
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Although the operational principle and performance of the IMS was previously 
described [71, 91], we provide a brief list of specifications in Table 8-1. The device is 
capable of recording 350 x 350 spatial x 42 spectral samples simultaneously at a frame 
rate up to 7.2 frames per second (FPS). A 3X zoom lens was attached to the existing 
distal optics of the IMS to obtain a FOV of 3 – 5 cm within the oral cavity. The spectral 
range was limited to 471 - 667 nm by a bandpass filter placed behind the camera lens. 
These wavelengths were selected because they contain spectral peaks of autofluorescence 
Figure 8-1: The clinical snapshot spectral imager has two mounted LEDs for 
autofluorescence and reflectance imaging. The device collects 350 x 350 spatial x 42 
spectral points simultaneously and is controlled with custom LabVIEW software on a 
laptop computer. 
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emission (i.e. collagen, NADH, FAD) and reflectance features (i.e. oxy- and deoxy-
hemoglobin). To provide reflectance and autofluorescence excitation of the tissue, we 
used two high-power light emitting diodes (LEDs). A 10W 405nm blue LED was 
selected for autofluorescence excitation, as this wavelength has been shown to 
significantly increase contrast of normal/abnormal lesions [110]. A 5W broadband white 
LED was selected for reflectance imaging. LED intensity was controlled with a USB data 
acquisition device.  
 
 
The illumination system, camera acquisition, and image display were 
synchronized using a custom LabVIEW interface. Shown in Figure 8-1, this program 
allows the user to switch between autofluorescence and reflectance imaging modes, 
adjust LED intensity, change display gain and color balance, and save datacubes. A real-
Table 8-1: Specifications for the snapshot imaging spectrometer. 
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time true-color representation of the datacube is also displayed. In order to match 
execution speed of image display with the 7.2 FPS frame rate of the camera, we chose to 
display a true-color representation of the datacube using only 3 spectral images. In other 
words the entire datacube is not used for real-time RGB display, but rather a subset of 
one spectral image from each of the red, green, and blue wavelength regions. However, 
the entire datacube is recorded when the user saves an image. The complete acquisition 
sequence (1) records the reflectance datacube and RGB image, (2) turns the white LED 
off and blue LED on, (3) increases camera exposure and gain, and (4) records the 
autofluorescence datacube and RGB image. This automated procedure, which saves a 
total of 42 x 2 spectral images, takes approximately 1 second.   
 
Calibration 
The raw data from the IMS device is a single encoded camera frame that contains 
all spatial and spectral information. Frame data must be reconstructed into a datacube 
using a geometric and spatial calibration procedure. Calibration of the device was 
performed according to the procedure in [71]. In addition, small defects within the optical 
train of the IMS can make the device less sensitive at localized areas of the datacube. 
Therefore, the device was flat-field corrected in reflectance mode using a certified 
reflectance standard (Spectralon) illuminated with a tungsten lamp. The spectra of the 
tungsten lamp was recorded with a point spectrometer and used to normalize the IMS 
spectra.  
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Pilot Clinical Study 
The device was first tested on normal volunteers at Rice University under IRB 
protocol 11-218E entitled “Noninvasive Method for Reflectance and Fluorescence 
Spectral Imaging of Oral Cavity and Skin in Normal Volunteers Based on the Image 
Mapping Spectrometer.” Clinical images were acquired under Rice University protocol 
07-62F and MD Anderson Cancer Center protocol 2006-0673 entitled “Oral Tumor 
Margin Detection Using Optical Spectroscopy.” All tissue was illuminated with settings 
below safety guidelines for UV and VIS-IR exposure.  
Patients having abnormal tissue resected from the oral cavity were considered 
eligible for the study. Data was collected from consenting patients using several optical 
devices: (1) the multimodal snapshot imaging spectrometer, (2) a standard widefield 
autofluorescence camera, and (3) a point spectroscopy device. When possible, data was 
collected from the lesions as well as a normal tissue site based on clinical impression. 
After data collection, biopsies were obtained from the lesion and normal site for 
pathological examination.  
8.3.  Results  
Device Characterization 
Although the snapshot imaging spectrometer was thoroughly characterized for 
other applications [71], we evaluated the device for spatial resolution, color balance, and 
excitation light rejection. Using a 1951 USAF resolution target we found the device could 
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resolve 200 µm features. A Macbeth ColorChecker chart was used to qualitatively assess 
color balance of reconstructed true-color datacube images. Rejection of excitation light 
was verified with a quartz disc, which showed less than 1:10 fluorescence ratio compared 
to the autofluorescence of normal tissue.  
We also measured the time to acquire a sequence of reflectance and 
autofluorescence datacubes. This metric is important because movement of the patient, 
clinician, or researcher during a long acquisition can cause motion blur or misregistration 
of spectral images. The device was set to capture reflectance and autofluorescence 
datacubes at 100 ms and 500 ms exposure, respectively. It took approximately 300 ms to 
adjust camera exposure/gain settings and to change white/blue LED intensities. Therefore 
the total time to collect all multimodal spectral datacubes was < 1 second. Spectral 
images within each datacube had > 99% coregistration, but sometimes a small spatial 
shift occurred between sequential reflectance/autofluorescence acquisitions.  
 
Oral Cavity Imaging Results  
Data was collected from normal volunteers and eleven patients using the snapshot 
imaging spectrometer. Reflectance datacubes were acquired with an exposure setting of 
100 ms and gain of 0 dB. Autofluorescence datacubes were acquired with an exposure 
setting of 500 ms and a gain of 20 dB. Figure 8-2 shows reflectance datacube spectral 
images from the lower lip of a normal volunteer. A plot of absorbance of the tissue 
reveals characteristics oxy-hemoglobin peaks. In addition, vascularity patterns can be 
visualized at different depths corresponding to wavelength. This effect is caused by the 
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dependence of wavelength on light penetration depth into tissue, which is primarily 




Figure 8-3 shows images from an abnormal tissue site from a patient. Figure 
8-3A/B are true-color images that were reconstructed from the reflectance and 
autofluorescence datacubes, respectively. Figure 8-3C is an image from the standard 
widefield autofluorescence camera, which reveals similar autofluorescence as the 
snapshot imaging spectrometer. Figure 8-3D shows a suspicious region determined by 
calculating the red/green ratio of the true-color datacube reconstruction.  
Figure 8-2: Reflectance spectral images from the lower lip show vasculature at different 
depths. 
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Figure 8-3: Images from a patient diagnosed with oral cancer. Reflectance (A) and 
autofluorescence (B) true-color images from the snapshot imaging spectrometer show an 
abnormal region of tissue. An image from a standard widefield autofluorescence camera 
(C) shows similar autofluorescence distribution. Using the red/green ratio, an abnormal 
tissue region can be identified (D). Standard widefield image from Richard Schwarz.  
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Figure 8-4 shows reflectance and autofluorescence spectra from different tissue 
regions in Figure 8-3, which were obtained in real-time by the snapshot imaging 
spectrometer. Compared to the spectra of normal tissue, abnormal and keratinized tissue 
exhibits a loss of overall reflectance intensity. Keratinized tissue also shows diminished 
oxy-hemoglobin peaks. Autofluorescence spectra of abnormal tissue show an overall 
decrease in intensity, a relative decrease in blue/green intensity, and increase in red 
intensity. Keratinized tissue shows significantly increased red autofluorescence, which is 




This work described a new optical modality for oral cancer imaging. A 
multimodal snapshot imaging spectrometer was constructed and is capable of streaming 
true-color images at 7.2 FPS and saving reflectance and autofluorescence datacubes in < 
Figure 8-4: Reflectance and autofluorescence spectra from different tissue regions. 
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1 second. The device was used to acquire spatial and spectral data in vivo from normal 
volunteers and eleven oral cancer patients. Samples images and spectra are shown for 
normal and abnormal regions of tissue.  
While this chapter demonstrates a new optical modality suitable for clinical 
studies, the work would benefit from further data analysis. Information such as number of 
normal and abnormal sites, disease pathology, and anatomical site will be tabulated. 
Pathology results and clinical impression will be used as a training set for a diagnostic 
algorithm. We will perform datacube analysis using algorithms such as k-means 
clustering, spectral unmixing, linear discriminant analysis, and principal component 
analysis. The result of this work will be a novel device and algorithm for point-of-care 
early oral cancer diagnosis. 
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In summary, this dissertation has presented several new optical imaging 
techniques for cancer diagnosis. The work details improvements in a two-part cancer 
detection procedure, which uses widefield imaging to survey a large region of tissue, and 
then high-resolution endomicroscopy to provide the final diagnosis.  
The first half of the dissertation describes four improvements to endomicroscopy. 
An algorithm to expand the effective field-of-view of endomicroscopes was developed 
and validated on several tissue specimens. While this technique was implemented on a 
fiber-bundle based endomicroscope, it can be applied to any endomicroscopy device. 
Next, two methods to improve axial response were described. These low-cost, user-
friendly devices were constructed and compared. The solutions provide better 
visualization of glandular tissue, increased contrast, and can be used to image beneath the 
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tissue surface. Finally, a technique to improve lateral resolution of endomicroscopes was 
presented. This work is useful when small subcellular features need to be visualized and 
for imaging tissue that is difficult to access. Additionally, these devices serve as a 
platform for imaging with miniature objective lenses. High-quality, low-cost miniature 
optics can be used to further increase lateral resolution and depth sectioning.  
The second half of the dissertation describes the development of a new widefield 
imaging modality. A description of the operational principle, calibration, and 
characterization of the spectral imaging device was presented. Next, the technique was 
configured to acquire widefield spectral images in autofluorescence and reflectance 
modes for oral cavity imaging. The device was tested on several tissue specimens and 
used to acquire data from eleven patients with oral cancer. Data acquired from this 
technique provides spectral information that can be correlated to disease progression.  
Results from this work could enable identification of key spectral imaging features that 
can be used to discriminate cancer from benign conditions such as lichen planus, 
hyperkeratosis, and inflammation. The future of this work includes further spectral 
images analysis and larger clinical studies.  
This work provides advancements to widefield and high resolution imaging for 
cancer diagnostics. Further research should aim to combine these techniques into a single 
system used for two-step “bi-FOV” detection. This work could impact areas of research 
besides cancer diagnosis. Improved optical imaging techniques can be used for detection 
of other diseases and for in vivo animal studies.  
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Appendix A 
Rapid, low-cost optomechanical design and 
prototyping: the plastic imaging spectrometer 
  
 This appendix focuses on the evaluation of plastic rapid prototyping as a 
technique for producing functional optomechanical parts. In our research setting, rapid 
prototyping can be more effective than CNC milling in terms of production time and cost. 
We describe a rapid prototyping procedure to print rigid plastic components for a 
research device called the Image Mapping Spectrometer (IMS). Results from plastic 
printing show precision alignment and fitting features can be manufactured faster than 
with metal milling. Plastic components provide opaque optomechanical structures at a 
fraction of the cost of metal milling ($1,000 vs. $10,000).  
Introduction 
 Here we describe the design, construction, and testing of custom plastic 
optomechanics for an Image Mapping Spectrometer (IMS) used in cellular research and 
clinical studies. The IMS is an imaging spectrometer that consists of an image mapping 
mirror, relay/dispersive optics, and a CCD camera. A durable, rigid enclosure is 
important to precisely align the numerous optical components within the IMS and to 
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shield them from external light. A previous version of the IMS was constructed from a 
shell of custom metal plates. Although the metal components provided adequate 
alignment precision and stray light protection, producing the system required 1-3 months 
of production time and a cost of over $10,000. Consequently, machining custom 
optomechanics was prohibitive for our application. As a research device, the IMS 
frequently requires physical modifications to its design. Consequently, rapid prototyping 
is ideal as a more cost/time efficient method of creating components for the device. 
Through an analysis of part design, component printing, and post processing, we 
determined 3D plastic printing to be a practical alternative to traditional metal milling. 
Methods 
 This section details design considerations, provides information about the printing 
process, and discusses the features of a 3D printer called the Projet SD 3000. Finally, 
methods used to post-process printed plastic pieces are presented. 
Design Considerations 
 Several design modifications were made to the original metal IMS in order to 
make a functional plastic prototype. The modifications provide structural stability within 
the new plastic system, incorporate threads, and integrate precise mounting and 
alignment features. First, the shell of the original IMS consists of eight long, thin metal 
plates – one of which is shown in the figure below. The thickness of the plate provided 
adequate rigidity when constructed from metal, but caused bending and warping when 
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printed with plastic. Simply increasing the total thickness would increase the overall size 
and cost of the system. In order to provide additional strength without significantly 
increasing the thickness of the plastic part, patterned structural features were added to the 
inside of each plate. For each IMS shell piece, the support features required an additional 




 Another feature that was added to the original metal design was custom screw 
threading. In the metal design, threads were indicated with annotations but not physically 
drawn into the model. Typically, smaller threads are cut with a drill bit and a specialized 
tapping tool, which requires several steps for each thread location; the process for cutting 
larger screw threads (greater than 1 in.) is even more tedious. Given the precision and 
ease with which rapid prototyping creates arbitrary structural features, we found that 
Figure: (left) is the drawing representing a side component of the IMS’s metal shell. 
Triangular additions were appended to the shell’s spine to provide additional structural 
support for the plastic version (right). 
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printing threads provided convenient time and cost savings. Our custom procedure for 
drawing a thread is shown in the figure below. Threading involves extruding a hole 
through a surface, overlaying a helix with a specified pitch, and then extruding a triangle 
along the path of the helix. Within the complete design of the IMS shell, we implemented 
49 custom threads.  
 
 An additional design modification that we implemented was press-fitted mounts 
for optical components. Press-fitting involves the connection of two separate entities, 
held together by friction after an initial force has been applied to join the pieces. In the 
metal system, press-fitting was not possible because of the parts’ high rigidity. Rapid 
prototyping in plastic is ideal for press-fitting because of its flexible substrate, high-
precision, and the ability to quickly iterate feature sizes if necessary. We implemented 
Figure: A cylinder is extruded through a component and given a helix with a pitch of 1/32 
in. An equilateral triangle is drawn between one pitch and used to make an extruded cut 
across the helix. 
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press-fitting in the lens array component of the IMS. The mounting part consists of 24 
holes arranged in a 4 x 6 configuration. Each hole is printed to the nominal diameter of 
each lens and includes a stop for depth positioning. The figure below shows a partially 
press-fitted lens array.  
 Along with press-fitted mounts, other custom precision alignment features in the 
plastic design helped to reduce system cost and assembly time. One of these alignment 
features was a structural support for the prism array assembly, which consists of a 
rectangular base with protruding cylinders. The prisms are placed between two adjacent 
protrusions. Neither adhesives nor threads were needed to keep the prisms stationary.  
 
Figure: (left) Lenses are press- fitted into an array without the use of any adhesives. 
(Right) The cylindrical protrusions on this rectangular base are used to keep a prism array 
stationary.  
Printing 
 This section describes a procedure for loading 3D files onto the Projet SD 3000 
and printing plastic components with high resolution. The resolution of the Projet SD 
3000 3D printer is 375 x 375 x 790 DPI, allowing the creation of plastic models with an 
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accuracy of 0.001-0.002 in. per in. of product. Plastic printing requires a three-
dimensional blueprint in the form of a .STL file, which is a format that describes the 
triangulated surface geometry of part. The .STL file approximates the surfaces of a three-
dimensional blueprint with polygons, and Projet recreates the polygons layer by layer 
during a print job. The figure below illustrates how a .STL file is uploaded onto the Projet 
software’s virtual image of a metal printing plate. The .STL file may be moved to any 
coordinate on the plate, a feature that allows users to fit multiple files on the printing 
plate at once. We found that printing parts vertically significantly increased resolution of 
the part, although this significantly increases printing time.  
 
Figure: Printing a part with vertical orientation maximizes the printed resolution. 
Post-Processing 
 The 3D printer creates the plastic part encased in a wax support. To remove the 
wax, the part is placed in a convection oven called the Projet Finisher. Excess wax 
deposits are then eliminated in an ultrasonication oil bath (Fig. 7b). Detergent is used to 
wash off any wax and oil on the plastic. In addition,  the plastic used for our application 
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needs to be opaque to prevent ambient light from entering the system. Two possible post-
processing methods for treating plastic include black dying and the application of vinyl 
sheets. The first method involves immersing the plastic pieces into a black ink bath for 
two hours and set overnight to dry. A second method employs the use of black, adhesive 
vinyl. Vinyl is placed over the desired surfaces of a print job and cut to fit the outline of 
the plastic pieces. The results of each approach are shown in the figure below 
 
Figure: The IMS shell can be given an opaque surface with black ink or adhesive vinyl. 
Results  
 The figure below displays the complete plastic model of the IMS. The plastic 
shells, with increased structural strength, provide sufficient resistance against physical 
wear during IMS usage. We found that the use of plastic offers additional benefits that 
include precision press-fitting and precision alignment, which are techniques that can be 
used to eliminate the need for adhesives when joining optical components to metal. 
Savings for time and cost can range from 50% up to 90% when replacing labor intensive 
techniques such as metal milling with rapid prototyping. While metal machining could 
require 1-3 months to create the IMS shell, plastic printing accomplishes the same goal in 
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approximately two days. The speed that plastic printing can output plastic models allows 
the user to work through several iterations of an optomechanical parts. The lengthy 
production time for the metal system results in an equally large monetary cost of > 
$10,000. A plastic device with sufficient structural integrity can be printed at the cost of 
~$1,000 by avoiding labor costs. These results support plastic printing as viable solution 
for manufacturing precise and rigid optomechanical parts. 
 
Figure: The complete IMS contains a protective shell that holds the optomechanics. A 
transparent view of the IMS shell reveals numerous threads that have been extruded into 
the shell components. 
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Appendix B 
IMS Calibration Summary: Slit-scanning  
 
This appendix describes an alternative to the pinhole scanning technique for 
geometric/spectral calibration of an imaging spectrometer. The spatial point-source can 
be replaced with a spatial line-source. Instead of scanning to every spatial position (x * y 
locations), a line can be scanned once along each spatial dimension (x + y locations), 
while saving images at each slit location. After data collection, images from any two 
perpendicular locations can be computationally combined, with the intersection 
representing a single spatial point. In the case of the IMS, this requires 0.57% the 
acquisition time of the point-scanning approach, approximately two hours, yet describes 
the same transformation. This principle is explained in the figure below. The following 
sections describe how spectral line-scanning was implemented for calibrating the IMS. 
A custom setup was built to implement spectral slit-scanning calibration in the 
laboratory. A 5 µm slit (Thorlabs) was used as the spatial line-source. It was mounted to 
two motorized translation stages (Newport) and positioned at the sample plane of a 
standard microscope (Zeiss AxioVert). Using a 5X microscope objective, the slit was 
magnified to about half the facet width of the mapping mirror. Wavelength tunable trans-
illumination was achieved with a halogen lamp and a liquid crystal tunable filter (CRI), 
which provided light with a spectral full-width half-maximum of approximately 10 nm. A 
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daylight filter and neutral density filter were also included to flatten the spectrum of the 
halogen lamp.  
 
 
Figure: Concept of line-scanning to obtain system response matrix. (A) A line of 
monochromatic light is scanned to every spatial-spectral point of object space (x, y, λ), 
shown here projected on a simplified mapping mirror. (B) A detector image is recorded at 
each scan position. (C) Each image is analyzed for spatial-spectral point spread functions; 
here the width is due to the spectral bandwidth used. The subpixel peak (*) of these areas 
on the detector (u, v) correspond to the position of the scan in object space (x, y, λ). (D) 
A single perpendicular scan determines the linear arrangement of detected peaks. (E) All 
subpixel locations are saved into a lookup table that represents the transformation matrix 
of the system.  
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Calibration settings were chosen based on the parameters of the IMS. The device 
was designed to acquire 350 x 350 spatial samples over a FOV of 250 μm with 48 
spectral channels between 450 – 650 nm. The tunable filter was programmed to sample 
the spectral λ dimension at ten evenly spaced steps between 450 – 650 nm. The spatial y 
dimension was sampled at 120 even spaced locations. In order to accurately determine 
the order of facets, the non-contiguous x dimension was sampled at 700 locations for only 
the 650 nm wavelength.  
Once data was collected from the calibration scans, there were several post-
processing steps required to obtain the inverse mapping transformation. The following 
sub-sections describe each part in detail.    
Calculating Sub-pixel Detector Locations from Y-Scan Data 
The first goal in processing the calibration data was to identify the locations (u, v) 
of point spread functions (PSFs) within every scan image. For each image there were 
approximately 350 PSFs corresponding to the number of facets in the mapping mirror. 
Each PSF on the detector was two to three pixels tall and five to six pixels wide; the 
vertical dimension corresponded to the spatial PSF and the horizontal dimension to the 
spectral bandwidth of the light. As a first step, dead pixels and hot pixels were eliminated 
from the data with thresholding and a morphological area opening operation. Weighted 
centroids were then calculated for all remaining areas in order to approximate sub-pixel 
locations of PSFs on the detector.  
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Reducing Noise and Filtering Weighted Centroid Data 
Typically several invalid centroids were detected. These points were filtered out 
based on the fact that the combination of all PSF images from one wavelength should 
trace approximately 350 lines (facet images) on the detector. Using this assumption, 
calibration images for a given wavelength were summed and morphologically dilated to 
produce a boundary region where valid PSFs should appear. Outside points were 
eliminated with a morphological area opening operation, as shown in the illustration 
below.     
 
Figure: (Left) A subsection of the detector, with centroid locations for one wavelength 
shown in red. Blue represents the centroids that were eliminated during noise filtering. 
(Right) A subsection of the detector, with facet clusters color-coded for one wavelength. 
Each color represents a cluster of centroids from one mirror facet. The hue of the color 
represents the spatial position it belongs in the reconstructed cube.  
Assigning Additional Dimensions to Centroid Points 
Remaining centroids were assigned five parameters that described their position 
in detector space (u, v) and object space (x, y, λ): the sub-pixel coordinates on the detector 
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indicated the (u, v) values, the y-scan position indicated the y value, and the filter 
wavelength the λ value. Centroids corresponding to the 650 nm edge wavelength were 
assigned x values based on the x-scan position that yielded the highest peak intensity 
value at (u, v). In other words, the x-value indicated the order in which lines were 
illuminated during the x-scan. Centroids from all other wavelength were assigned x 
values as described in Section 3E.  
Cluster Analysis to Identify Facet Image Locations 
After processing calibration images from the 650 nm wavelength scan, a set of 
about 35,000 points with five dimensions had been identified. Cluster analysis was used 
to organize this data. First, a distance was calculated between every centroid in five-
dimensional Euclidean space. For example, centroids that were adjacent in (u, v) detector 
space but far apart in (x, y, λ) object space were assigned a value between the two 
distances. Using this distance value, centroids were organized into clusters that 
corresponded to facets on the image mapper. A distance cutoff of 20 pixels worked to 
achieve this separation, because it was less than the distance between two adjacent facet 
images in (u, v) detector space, yet greater than the separation between adjacent points 
within a facet. Finally, all clusters were put in order, from 1 to 350, based on the average 
x value of the contained points.  
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Figure: Color-coded facet clusters for all wavelengths. The hue represents the spatial 
position in the reconstructed cube. Each vertical line within a color group represents a 
wavelength position in the cube. 
